







METABOLIC ENGINEERING OF YEAST STRAINS FOR RENEWABLE BIOMASS 
















Submitted in partial fulfillment of the requirements 
for the degree of Doctor of Philosophy in Food Science and Human Nutrition 
with a concentration in Food Science 
in the Graduate College of the 







 Associate Professor Michael J. Miller, Chair 
 Associate Professor Yong-Su Jin, Director for Research 
Associate Professor Manabu T. Nakamura  




The overall goal of this thesis study is to use metabolic engineering and biotechnology 
tools for developing optimal yeast strains capable of utilizing various sugars derived from 
renewable biomass and produce valuable chemicals. Sugars derived from lignocellulosic 
biomass, mainly cellobiose and xylose, cannot be assimilated by the industrial microorganisms, 
such as yeast Saccharomyces cerevisiae. To utilize cellobiose or xylose for the fuels and 
chemicals production by S. cerevisiae strains, heterologous expression of cellobiose or xylose 
metabolizing genes are required. The first part of this dissertation focuses on developing optimal 
yeast strains for utilizing renewable sugars, cellobiose, xylose and galactose, and 
understanding underlying mechanism for improvement on lignocellulosic sugar utilization. 
Initially, cellobiose fermenting S. cerevisiae was developed by expressing Neurospora 
crassa cellodextrin transporters (CDT-1 and CDT-2) and β-glucosidase (BGL) or cellobiose 
phosphorylase (CBP) to breakdown cellobiose into hexose units. In various cellobiose 
fermentation conditions, the strains expressing CDT-1 showed efficient fermentation compared 
to the strains expressing CDT-2. Also, strains expressing BGL had better cellobiose 
fermentation compared to CBP. However, I hypothesized expressing CDT-2 and CBP might 
have a beneficial effect under energy-limiting conditions (such as industrial fermentation 
environment) due to minimal ATP requirement compare to pairing with/or CDT-1 and BGL. 
Because the rate of cellobiose fermentation with CDT-2 and CBP were very inefficient, 
laboratory evolution approach was employed to enhance cellobiose utilization. I isolated an 
evolved strain that harbored one SNP change in CDT-2 that is responsible for enhanced 
cellobiose utilization. With evolved CDT-2 and CBP, cellobiose fermentation rate improved 
drastically.  
Previous studies successfully developed xylose-utilizing S. cerevisiae strain. However, 
the overall fermentation efficiency of the strain is relatively poor. Additionally, using different 
strain backgrounds resulted in various patterns of the xylose utilization. This variation is 
presumably caused by the genotype differences among the strains. Thus, I hypothesized the 
xylose-utilizing trait is a complex trait which phenotypes result from a multiple genes interaction. 
Quantitative Trait Locus (QTL) mapping strategy was used to identify ‘hotspots’ in the genome 
responsible for enhanced xylose utilization. The identified QTLs reveal that enhanced xylose 
fermentations are likely very complex due to many detected QTL. Also, previously reported 
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gene targets that may improve xylose fermentation was not detected. This result indicates 
complex genetic interactions are responsible for xylose fermentation. Although specific genetic 
targets were not identified, our results show genome shuffling of two highly variable strains is a 
very effective methodology to obtain an efficient xylose-fermenting strain with minimal genetic 
engineering.   
Galactose is abundantly found in marine biomass and hemicellulose from plant cell wall. 
Although yeast can naturally metabolize galactose, consumption rate and overall ethanol yield 
are usually lower compared to glucose. While screening various gene targets related glucose 
sensing, regulation and metabolism, TPS1 deletion expressed with mutant HXK2 allowed 
enhanced glucose or galactose fermentation. Because HXK2 also has a role in glucose 
signaling and repression, a mutation caused a change in this property. By deleting TPS1 and 
expressing mutant HXK2, yeast effectively utilized glucose and galactose under mixed sugar 
condition whereas wild-type strain could not consume galactose in the presence of glucose. 
Following renewable sugar utilization by engineered strain, the second part of this 
dissertation investigates on chemical production by engineered yeast. To replace current 
chemical production system, diversification of product formation by the microbial system is 
necessary. I identified 2-isopropylmalate (2-IPM), and intermediate of leucine biosynthesis, as a 
target chemical production in yeast. The dicarboxylic organic acids are favorable for production 
due to possible bio-based polymer synthesis. I observed 2-IPM accumulation by deleting LEU1 
and further optimized the strain by removing nitrogen catabolite repression (∆URE2), leucine 
feedback inhibition (mutant LEU4) and increase pyruvate flux to leucine biosynthetic pathway 
(Bacillus subtilis AlsS). Also, fermentation media optimization was performed. From no 
accumulation of 2-IPM by wildtype yeast, 0.033 g/g yield was achieved by optimizing strain and 
fermentation condition. At scale-up fermentation, 2-IPM titer reached 25 g/L by glucose-limited 
fed-batch strategy. After 2-IPM overproduction had been achieved, various prospective 
applications were explored. First, polymer synthesis derived from 2-IPM was investigated. By 
converting 2-IPM to anhydride form then reaction with epoxide yielded biodegradable elastomer. 
Also, taking advantage of the organic acid identity of 2-IPM and skin-whitening effect by 
inhibiting melanin formation was investigated.  
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In summary, this research demonstrates effective metabolic strategy employed for 
developing yeast strains capable of fermenting lignocellulosic sugars and diversified chemical 
production by discovering new target chemical with many projected applications.  
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CHAPTER I: Introduction to Microbial Engineering for Sustainable Fuels and Chemical 
Production Process 
 
1.1 General Introduction 
As human society and population have grown, the demand of commodity fuels and 
chemicals also increased. To supply the increasing demands, utilization energy sources such as 
fossil fuels prospered. Most of current fuels and chemicals production directly or indirectly 
utilizes non-renewable and unsustainable fossil fuel resources. For example, predominant fuels 
such as gasoline and jet fuels are processed directly from fossil fuels. Also, chemicals such as 
olefins and aromatics, widely used across all industries, are petrochemicals [1, 2]. Fossil fuels 
became an essential energy source, and humans rely heavily on making up approximately 80% 
of overall energy needs [2, 3]. Although fossil fuel-based fuels and chemical productions are 
well-established, the current process is frequently challenged for its sustainability for the future 
[1].  
There are two primary problems that fossil fuels disqualify for future resources. Fossil 
fuels are resources that formed around 370 million years ago during the Carboniferous age. 
Because fossilization process takes millions of years, fossil fuel based resources are considered 
finite. However, the current rate of fossil fuel usage greatly outpaces the rate of its formation. At 
the current rate of fossil fuel usage, fossil fuels are likely to go extinct in 40-50 years [4]. Fossil 
fuels are simply non-renewable and unsustainable resources for the future. Secondly, fossil 
fuels cause a detrimental effect on the environment. When fossil fuels are burnt, major air 
pollutants are produced. Among pollutant, production of carbon dioxide, one of the greenhouse 
gasses, became a strong concern due to its major responsibility of causing climate change and 
global warming [4-7].  
Many alternative solutions have been proposed to resolve the current issue faced by 
fossil fuels. Among many proposed solutions, synthesis of bio-based and renewable products 
have gained global interest [8]. Prominently, production of fuels and chemicals using microbes 
expanded rapidly over the last few decades gradually replacing current petroleum refineries [9, 
10]. For example, bioethanol production by yeast fermenting corn or sugarcane-derived sugars 
are widely accepted in the society [11]. Despite the successfulness of bioethanol production by 
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yeast, however, its production from food crops are highly controversial due to limited arable land 
and increasing food scarcity [2, 12, 13]. Additionally, production of bioethanol only can replace a 
small fraction of current fossil fuel based chemical production [14, 15]. Thus, to overcome major 
challenges for microbial synthesis of fuels and chemicals, at least three specific characteristics 
should be considered: 1) capable of metabolizing non-food and renewable resources efficiently 
and rapidly, and 2) capable of producing targeted chemicals. To address the challenges by 
current microbial synthesis, methodologies from metabolic engineering and synthetic biology 
have been employed. 
 
1.2 Microbial fermentation with renewable resources 
Current biorefineries producing fuels and chemicals by microbial fermentations require 
fermentable substrates (feedstock). Commonly, sugars derived from sugarcane or corn starch 
have been used for a long time as the fermentable resources [16, 17]. Glucose and fructose are 
the major sugars derived from sugarcane and corn and fermented by Saccharomyces 
cerevisiae, traditional industrial yeast. However, recent ethical criticism of using food resources 
for fuels and chemical production directed researchers to find alternate non-nutritious 
feedstocks [18]. Also, utilizing sugarcane and corn feedstocks is unsustainable because the 
current production of these crops is limited for replacing all fuels and chemical needs as well as 
using as a food source [18]. Thus, utilizing non-food, sustainable and renewable sources such 
as lignocellulosic biomass from agricultural residues, wood wastes, or energy crops and marine 
biomass from red seaweed has been proposed replacing the feedstock from sugarcane and 
corn [13, 19-21].  
Lignocellulosic biomass is composed of carbohydrate polymers (cellulose and 
hemicellulose), that are tightly bound to lignin. Thus, pretreatment and hydrolysis of 
lignocellulosic biomass are necessary to release fermentable sugars. During hydrolysis process, 
both hexose and pentose sugars are released, among which glucose and xylose are major 
sugars [22]. Then glucose and xylose can be utilized as a substrate for microbial fermentations. 
In the case of marine macroalgae, galactose is major hexose sugar obtained from hydrolysis 
process that can be used as the substrate [13, 23]. Therefore, efficient utilization of renewable 
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sugars in the placement of glucose from sugarcane or corn is the key to establishing a feasible 
and sustainable process for the fuel and chemical production. 
Xylose utilization by S. cerevisiae 
At industrial scale production of fuels and chemicals, host microorganisms should be 
able to metabolize the given substrates and produce the target chemicals efficiently and 
productively [24]. Saccharomyces cerevisiae, a robust and efficient yeast strain capable of 
converting glucose to ethanol, is commonly used for microbial fermentations due to its capacity 
at an industrial scale. However, native S. cerevisiae lacks metabolic pathways to utilize xylose. 
Therefore, the species cannot metabolize xylose to produce a target chemical. To allow xylose 
fermentation by S. cerevisiae, a xylose assimilation pathway should be introduced to the strain.  
Numerous studies attempted to engineer the S. cerevisiae strain capable of fermentation 
xylose during last decade [25-30]. Commonly, the xylose-fermenting S. cerevisiae strains are 
developed by heterologous expression of fungal xylose reduction-oxidation (XR/XDH) pathway 
or bacterial xylose isomerization (XI) pathway. The XR/XDH pathway taken from native xylose-
fermenting yeast such as Scheffersomyces stipitis consists of expressing three primary genes, 
XYL1, XYL2 and XYL3 encoding xylose reductase, xylitol dehydrogenase and xylulokinase, 
respectively (Figure 1.2A) [28, 30-32]. Xylose is reduced to xylitol by XR with cofactor NAD(P)H 
followed by oxidation of xylitol to xylulose by XDH with cofactor NAD+. Xylulose is 
phosphorylated to xylulose-5-phosphate by XK then metabolized further via pentose phosphate 
pathway that is native to S. cerevisiae. Although native xylulokinase (encoded by XKS1) exists 
in S. cerevisiae, often XK from S. stipitis is co-expressed with XR and XDH for optimized 
expression with XYL1 and XYL2 [29, 30]. The heterologous expression will allow xylose 
fermentation in engineered S. cerevisiae. However, the introduction of enzymes requiring 
additional cofactors breaks the natural cofactor balance allowing intermediate product 
accumulation, especially xylitol [25, 33]. Unfavorable intermediate accumulation reduces the 
efficiency of the designed pathway and creates a cost-ineffective process. Also, cofactor 
imbalance can affect the efficiency of the pathway, reducing the xylose consumption rate [33, 
34]. On the other hand, the XI pathway typically taken from Piromyces sp. consists of xylA 
encoding for xylose isomerase and overexpression of xylulokinase [35-37]. Xylose isomerase 
allows direct conversion of xylose to xylulose and converts to xylulose-5-phosphate by either 
heterologous or native XK expression. Unlike XR/XDH pathway, XI pathway does not require 
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additional cofactors. Thus, efficient xylose fermentation under anaerobic conditions and higher 
ethanol yield is permitted.   
Despite the extensive research to enable efficient xylose fermentation with engineered 
yeast, fermentative yield and productivity using either XR/XDH or XI pathway have not reached 
the level of glucose fermentation. Thus, several researchers directed their efforts to identify and 
resolve the bottlenecks of efficient xylose fermentation. Initially, the effective of overexpression 
of pentose phosphate enzymes was investigated. In general, overexpression helped to increase 
xylose fermentation capability [37-40]. Specifically, overexpression of TAL1, encoding 
transaldolase converting sedoheptulose 7-phosphate and glyceraldehyde 3-phosphate to 
erythrose 4-phosphate and fructose 6-phosphate, have shown to increase the efficiency of 
xylose fermentation significantly [16]. Still, however, xylose fermentation is not comparable to 
glucose fermentation in yeast. Further elucidation of xylose metabolism in yeast remains 
unsolved.  
Advantage and remaining challenges of using cellobiose as a fermentable sugar  
 The cellulose component from lignocellulose is primarily composed of glucose units 
bound by a strong β(1→4) glycosidic linkages. Saccharification of cellulose requires groups of 
cellulose enzymes, commonly endo-and exoglucanases for hydrolyzing cellulose to 
cellodextrins and β-glucosidase for hydrolysis of cellodextrin to glucose. However, 
saccharification of cellulose by a mixture of cellulolytic enzymes can be challenging. As the β-
glucosidase activity of fungal cellulolytic enzymes is weak, intermediates of cellulose hydrolysis 
cellobiose (and cellodextrins) will accumulate to inhibit cellulolytic enzymes. Also, end-product 
glucose will inhibit overall enzymatic activity lowering the overall efficiency of saccharification 
process.  
 Another critical barrier to using lignocellulosic hydrolysate is glucose repression exerted 
by end-product of cellulose saccharification. As mentioned earlier, main monomeric sugars 
derived from lignocellulose are glucose and xylose. In the end, microorganisms should be able 
to consume both sugars simultaneously to allow efficient bioconversion. However, in the 
presence of glucose, cells prioritize utilization of glucose then consume other sugars only after 
glucose is depleted from the media. This sequential utilization of sugars is a significant barrier to 
maximize the efficiency of lignocellulosic hydrolysates.  
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To bypass both inefficient saccharification process and bottlenecks caused by glucose 
repression, utilization of cellobiose have been proposed [41]. Cellobiose is a dimer of two 
glucose units bound by β(1→4) glycosidic linkages and shortest cellodextrin unit from 
saccharification process without β-glucosidase activity. Hence, cellobiose metabolism mainly 
will be done by native pathway glycolysis. However, though S. cerevisiae is an excellent 
glucose fermentor, they cannot assimilate cellobiose. Thus, metabolic engineering of S. 
cerevisiae is necessary to enable cellobiose fermentation.   
 Cellobiose fermentation in S. cerevisiae essentially require two additional heterologous 
expressions: 1) cellodextrin transporter to transport cellobiose into the cell and 2) hydrolyzing 
enzyme to break cellobiose to monomeric sugar (Figure 1.2B). Previous studies have shown 
expression of both cellodextrin transporter and hydrolyzing enzyme allows successful cellobiose 
fermentation in yeast [41-43]. The rate of cellobiose utilization, ethanol yield and productivity 
and cell growth on cellobiose differs by which transporter is expressed as well as which 
hydrolyzing enzyme it is co-expressed. There has been considerable debate on which pair of 
the transporter and the hydrolyzing enzyme is most efficient for yeast cellobiose fermentation. 
For cellodextrin transporters, two fungal cellodextrin transporters such as CDT-
1(NCU00801) and CDT-2 (NCU08114) from Neurospora crassa have been studied extensively 
[41-46]. CDT-1 was determined to be an active transporter (proton symporter, specifically) and 
CDT-2 was determined to be a facilitator transporting cellobiose via diffusion [43]. In general, 
CDT-1 had a superior cellobiose transportation compared to CDT-2. Being a proton symporter, 
CDT-1 co-transports one proton ion per cellobiose transport. Then yeast cells will pump out 
extra proton ion via Pma1p to maintain intracellular pH homeostasis and plasma membrane 
potential. This process requires energy and need extra ATP to use cellobiose as a substrate. 
On the other hand, CDT-2 does not require proton cotransport allowing no disturbance of 
intracellular pH homeostasis, therefore, does not require extra energy for cellobiose 
fermentation. For this reason, regardless of its superior cellobiose transport capability, there has 
been a significant debate on which transporter, CDT-1 or CDT-2, is more suitable for cellobiose 
fermentation.  
Once cellobiose in transported into the cell, either β-glucosidase (BGL) or cellobiose 
phosphorylase (CBP) can be used for hydrolysis of cellobiose. The BGL from N. crassa can be 
intracellularly expressed and hydrolyze cellobiose into two units of glucose, then metabolized 
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via glycolysis. The BGL coupled with CDT-1 or CDT-2 generally have higher cellobiose 
consumption rate compared to CBP [43]. However, ethanol yield from cellobiose fermentation 
with BGL is lower. During cellobiose utilization, BGL is very efficient hydrolyzing cellobiose into 
two glucose units, but also promote transglycosylation activity [47]. Thus, glucose units can bind 
to cellobiose and create undesired cellodextrins (cellotriose and cellotetraose). In comparison, 
the CBP from Saccharophagus degradans bypasses transglycosylation activity. The CBP 
directly phosphorylates one of the glucose units from cellobiose yielding one glucose-1-
phosphate and one glucose. Then glucose-1-phosphate and glucose can be metabolized by 
glycolysis [45]. Accordingly, cellobiose fermentation with CBP yields higher ethanol yield. 
However, the rate of cellobiose conversion by CBP is comparably slower than conversion by 
BGL. While successful cellobiose fermentation can be achieved by expression CDT-1 or CDT-2 
and CBP or BGL, the best system to utilize cellobiose remains problematic. 
Galactose utilization by S. cerevisiae 
 Galactose is a monosaccharide sugar abundantly derived from marine biomass such as 
macroalgae and industrial waste such as cheese whey [48, 49]. Native S. cerevisiae can utilize 
this sugar by Leloir pathway. Galactose is utilized by converting to glucose-6-p in few enzymatic 
steps, then metabolized via glycolysis (Figure 1.2C). However, due to a tight regulation of if 
Leloir pathway, specific galactose uptake rates and ethanol yields are significantly lower than 
glucose [50, 51]. Thus, previous studies attempted to improve galactose utilization by yeast by 
employing various strategies. For example, Ostergaard et. al. modified expression of galactose 
metabolic enzymes by deleting negative transcription regulators (GAL6, GAL80, and MIG1) and 
overexpressing transcription activator (GAL4) [52]. Additionally, SNR84 (encoding small nuclear 
RNA), TUP1 (general transcription repressor), and RAS2 (encoding for GTP-binding protein) 
[53, 54] were identified as gene targets affecting galactose metabolism. Despite many efforts of 
previous studies to improve galactose fermentation in S. cerevisiae, clear galactose metabolism 
governing mechanisms have not been elucidated that is necessary to improve galactose 




1.3 Value-added product formation by engineered yeast  
 Many of current chemical production rely on fossil-fuel derived resources such as 
petroleum. These petrochemicals include major chemical classes of olefins (i.e. ethylene, 
propylene) and aromatics (i.e. benzene, toluene) [55]. These olefins and aromatic chemical 
compounds are industrially significant and highly demanded due to its wide range of usage, 
from the synthesis of solvents, detergents, and adhesives. Especially, olefins serve as building 
blocks for synthesizing polymers used for the synthesis of plastics, fibers, rubber, gels, etc. [55, 
56]. Considering current usage and production of even plastics alone (produced over 300 million 
metric tons annually) [57], petrochemicals are an absolute necessity for modern society. 
However, due to the unsustainability of fossil fuels, petrochemicals are subjected to be replaced 
by a sustainable system. 
 The microbial fermentation system can be a sustainable option to replace current 
petrochemicals production. By engineering microbes and fermentation processes, I can 
manipulate the produced metabolite to our favor. Often, utilizing microbes for chemical 
production can be highly advantageous because complex bioconversion is readily performed  
[9]. Thus, increasing number of chemical production are attempted to be transferred to the 
microbial production platform. 
 Among many targeted chemicals for microbial production, organic acids have been 
gaining increasing attention from many industries. In general, organic acid, due to its carboxylic 
group with carbon chain and reactivity, holds great potential to serve as building blocks for 
synthesizing polymeric compounds [58]. For example, lactic acid can be produced by 
engineered S. cerevisiae with the introduction of heterologous enzyme lactate dehydrogenase 
[59, 60]. Then, produced lactic acid can go under few chemical reactions to produce polylactic 
acid (PLA). PLA is renewable and biodegradable plastic and already commercialized for 
producing various products such as plastic dining utensils [61].  
Succinic acid is another valued product that can be overproduced by engineered S. 
cerevisiae [62-64]. Because native S. cerevisiae can produce succinic acid under the aerobic 
condition without any genetic perturbation, succinic consuming reactions are removed by 
deleting genes such as SHD3, SER3, and SER33 [64]. Although resulting engineered strains 
displayed great improvement of succinic acid yield, on-going studies are focusing on improving 
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the yield to reach closer to the theoretical maximum. Also, despite the successfulness of few 
chemical production with the microbial platform, challenges of replacing all petrochemicals 
remains to be overcome. The various product formation from petrochemical makes difficult for 
microbial systems to replace all effectively. Thus, more microbial platform-based chemical 
synthesis should be discovered. 
1.4 Recent advances in biotechnology and metabolic engineering 
Metabolic engineering is a practice of optimizing genetic and regulatory systems within a 
cell to increase the productivity of chemical production via recombinant DNA technology [65]. It 
is a strategic and directed approach for the strain improvement thus requires a thorough 
understanding of the cellular system. Current cutting-edge technology development and 
advancement such as clustered regularly interspaced short palindromic repeats (CRISPR) and 
the CRISPR-associated proteins (Cas) system [11, 66, 67], global metabolite profiling [68, 69] 
and whole genome sequencing extended the limits of modification and analysis of the cellular 
system. This advancement allows rapid development of industrial yeast strains that can produce 
value-added chemicals efficiently and productively.  
A rational design of metabolic engineering takes a systematic approach to design the 
pathway for the most efficient production of the target chemical carefully. This method requires 
careful examination of target pathway stoichiometry, regulatory systems, and metabolic fluxes, 
thus requiring extensive prior knowledge of the cellular system [70]. Based on the rational 
design, necessary genetic changes are made such as the amplification and deletion of the 
native genes and the introduction of heterologous genes [71, 72]. The introduction of xylose and 
cellobiose metabolic pathway in S. cerevisiae is an example of the systematic approach. For S. 
cerevisiae to ferment xylose, the most plausible design is to adapt and introduce a pathway that 
converts xylose to xylulose-5-phosphate from other native cellular systems. Subsequently, 
native S. cerevisiae strains can utilize xylulose-5-phosphate via the pentose phosphate 
pathway. In the case of cellobiose utilization, cellobiose transporter and cellobiose hydrolyzing 
enzymes are introduced to convert cellobiose into glucose units. However, the rational design of 
metabolic engineering can be an effective approach to some extent; there are several 
limitations. Often, conducted pathway manipulations based on prior knowledge and careful 
design may result in unexpected results such as no phenotypic change and adverse effects on 
cellular functions [73]. Also, lack of available information on the cellular system can halt from 
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designing an effective pathway [74]. Likewise, engineered S. cerevisiae strain with xylose or 
cellobiose metabolism pathway allow the utilization of the sugars. However, the efficiency of the 
pathway was very low compared to the primary sugar metabolism such as glucose.  
To complement the limitations of a systematic approach, a combinatorial approach to 
metabolic engineering can be used. In contrast to the systematic approach that requires a 
thorough understanding of the cellular system, the combinatorial approach requires minimum 
prior knowledge of the cellular system. Instead of rational genetic perturbation then evaluating 
the phenotypes of the newly engineered strains, the combinatorial approach rather takes an 
inverse experimental flow. Random genetic changes are made, and cells that harbor useful 
phenotypes are screened and selected [75]. Construction of mutant strains with random genetic 
perturbation can be developed using tools such as a random mutagenesis, genomic library, and 
randomized gene knockout library. The pool of mutants can be screened and selected by high-
throughput screening tools such as flow cytometry or microfluidics devices [76]. Then, the 
beneficial mutations accumulated are identified by high-throughput sequencing. An example of 
combinatorial metabolic engineering is laboratory evolution. This strategy allows cells that make 
random genetic mutations that increase the growth and survival under the selective pressure. 
Several studies report the successfulness of laboratory evolution to obtain enhanced yeast 
strain. 
Both rational and traditional combinatorial metabolic engineering allows developing a 
strain with improved properties [77]. Many previous studies reported the successful application 
of both metabolic engineering approaches [78, 79]. Methodologies are often optimized for the 
monogenic effect of a phenotype that is affected by a single or a few genes. However, many 
observed phenotypes are often caused by the interaction of many genes, and underlying 
genetic network and mechanisms are complex. Thus, tools such as Quantitative Trait Locus 
(QTL) mapping analysis particularly or statistical analysis of the genome are often applied. 
Quantitative traits are a result of many interactions of the genes or a polygenic effect to 
the phenotype. Examples of the quantitative traits include industrially favorable phenotypes 
such as efficiency and productivity of the pathway, robustness, and resistances to stressful 
conditions. Thus, it is crucial to consider quantitative traits for engineering microbes for 
improved features. Traditional methodologies for identifying quantitative traits are depended on 
the two major factors: phenotypic (trait) evaluation and genotypic (genetic sequences) 
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evaluation. Quantitative Trait Locus (QTL) mapping analysis is a widely accepted analysis used 
in various fields of study such as plant biology, medicine, and microbiology [80]. Many studies in 
metabolic engineering of microbes performed QTL mapping analysis that allowed identification 
genetic targets for strain improvement [81-89]. The analysis allows linking statistically 
phenotypic and genotypic data for determining the genetic basis of the trait of interest.  
 
1.5 Motivations and research objectives 
 Owing to tremendous advances in metabolic engineering and biotechnology, the 
microbial production of fuels and chemicals envisioned to replace the current unsustainable 
fossil-fuel-based system. While several successful transitions to microbial system lay the 
foundation of the renewable process to produce fuels and chemicals, many barriers remain to 
be solved. For example, utilization of lignocellulosic sugars (xylose and cellobiose) in 
engineered S. cerevisiae strain allowed to move away from food-derived substrates (glucose 
and sucrose). However, lower efficiency of lignocellulosic sugar utilization is a major hindrance 
to replace the current system. Also, current chemical production with microbial fermentation 
cannot cover the current diverse petroleum-derived chemical production making microbial 
chemical production less practical.  
 Thus, this dissertation addresses the development of optimal yeast strains for utilizing 
lignocellulosic sugars, elucidation of underlying mechanisms related to carbon metabolism and 
extension of chemical production by engineered yeast. Specific objectives include: 1) Evaluation 
of cellobiose transporter for enhanced cellobiose fermentation, 2) investigate synergistic effect 
cellobiose transporter and hydrolyzing enzyme, 3) Investigate complex metabolic system for 
xylose metabolism, 5) genetic engineering for enhanced galactose fermentation, 5) produce 
novel chemicals, 2-isopropylmalate, by engineered yeast, and 6) prospective applications of 2-
isopropylmalate. In the future, I anticipate the outcome of these studies will have positive 








Figure 1.1 Schematic diagram of metabolic engineering of S. cerevisiae. Metabolic engineering 







Figure 1.2 Xylose, cellobiose and galactose metabolic pathway. Xylose and cellobiose are the 
major sugars found in lignocellulosic hydrolysates and galactose are abundant in marine 
biomass. (A) To utilize xylose, yeast requires several heterologous enzymes to convert xylose 
to xylulose-5-p. Xylose can be converted to xylulose by xylose isomerases (XI), or converted to 
xylitol by xylose reductase (XR) then to xylulose by xylitol dehydrogenase (XDH). Xylulose can 
be phosphorylated by xylulose kinase (XK) then utilized by pentose phosphate pathway. (B) To 
utilize cellobiose, cellodextrin transporter is required to transport cellobiose into the cell via 
active transport or diffusion. Then cellobiose can be hydrolyzed by beta-glucosidase (BGL) or 
phosphorylated by cellobiose phosphorylase (CBP). Resulting glucose or glucose-1-p can be 
converted to glucose-6-p by hexokinases and/or phosphoglucomutase (PGM) and further 
metabolized via glycolysis. (C) Native S. cerevisiae can metabolize galactose in several steps. 
Galactose is converted to galactose-1-p (GAL1), glucose-1-p (GAL7) and glucose-6-p (PGM) 




CHAPTER II: Analysis of Cellodextrin Transporters from Neurospora Crassa in 
Saccharomyces cerevisiae for Cellobiose Fermentation 1 
 
2.1 Introduction 
Saccharomyces cerevisiae has been widely used to produce ethanol from sugars 
derived from sugarcane and corn [90]. To avoid further impacting the food and feed markets, 
producing ethanol from non-edible crops has been proposed [91]. However, saccharification of 
cellulose into glucose requires substantial amounts of cellulolytic enzymes due to the presence 
of strong β(1→4) glycosidic linkages and the crystalline structure of cellulose, which makes 
cellulose relatively inaccessible to cellulolytic enzymes. Saccharification of cellulose mainly 
consists of two reactions: 1) hydrolysis of cellulose to cellobiose (and cellodextrins) by endo- 
and exoglucanases and 2) saccharification of cellobiose to glucose by β-glucosidase [92]. 
Because the main intermediates of cellulose hydrolysis (cellobiose and cellodextrins) strongly 
inhibit cellulolytic enzymes, rapid degradation of cellobiose into glucose is essential for efficient 
hydrolysis of cellulose.  However, most cellulose mixtures obtained through cellulolytic fungal 
cultures exhibit low β-glucosidase activity as compared with their endo and exo-glucanases 
activity. Thus, supplementation with additional β-glucosidase is often necessary during the 
saccharification of cellulose into glucose. This may significantly increase the costs of the 
process, as enzymes constitute a considerable portion (40-50%) of total costs for ethanol 
production from cellulose [93-95].  
To overcome the feedback inhibition by cellobiose on cellulases and relieve high 
enzyme cost, S. cerevisiae has been engineered to ferment cellobiose directly through the 
introduction of two heterologous genes that allow transport of cellobiose (and cellodextrin) and 
intracellular hydrolysis of cellobiose (and cellodextrin) to glucose [41]. Direct cellobiose 
fermentation via intracellular transport and hydrolysis will lead to the elimination of cellobiose in 









the cultures and efficient cellulose degradation without requiring β-glucosidase 
supplementation.  
Previously, several genes coding for putative cellobiose transporters including 
cellodextrin transporters (cdt-1 and cdt-2) from Neurospora crassa [41], lactose transporters 
(LAC1, LAC2, and LAC3) from Kluyvergomyces lactis, and putative hexose transporter 
(HXT2.1, HXT2.3, HXT2.4, HXT2.5, and HXT2.6) from Pichia stipitis [45] were identified. 
However, the exact mechanisms of cellobiose transport by those transporters have not been 
fully studied despite these transporters having exhibited diverse patterns of cellobiose utilization 
when expressed in S. cerevisiae by pairing with intracellular β-glucosidase(GH1-1) from N. 
crassa. In particular, different patterns of cell growth on cellobiose condition (including 
cellotriose and cellotetraose conditions) were observed between engineered S. cerevisiae 
expressing CDT-1 and CDT-2 from N. crassa, although both transporters were reported to have 
a very similar affinity to cellobiose [41]. As detailed biochemical characteristics of CDT-1 and 
CDT-2 have not been reported yet, this study was undertaken to investigate characteristics of 
engineered S. cerevisiae expressing CDT-1 or CDT-2 with GH1-1 for cellobiose fermentation. 
The mechanism of cellobiose transport by CDT-1 and CDT-2 was investigated, and profiles of 
sugar utilization by engineered S. cerevisiae during cellobiose fermentation were also 
investigated. 
 
2.2 Materials and methods 
Strains, plasmids, and culture conditions 
In the previous studies, cellobiose transporter genes from N. crassa FGSC 2489, 
NCU00801 and NCU08114 (cdt-1 and cdt-2), and an intracellular β-glucosidase gene (gh1-1) 
from N. crassa were cloned into a pRS426 plasmid (URA3, PGK1 promoter, CYC1 
transcriptional terminator) and a pRS425 plasmid (LEU2, PGK1 promoter, CYC1 transcriptional 
terminator), respectively [41]. The resulting plasmids were pRS426-cdt-1, pRS426-cdt-2, and 
pRS425-gh1-1. S. cerevisiae YPH499 (MATa ura3-52 lys2-801_amber ade2-101_ochre trp1-
Δhis3-Δ200 leu2-Δ1) [96] was used for the cellobiose transport assay. S. cerevisiae D452-2 
(MATα leu2 his3 ura3 can1) [97] was used for characterization of cellobiose transporters after 
expressing CDT-1 or CDT-2 along with GH1-1 under various fermentation conditions. All strains 
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and plasmids used in this study are listed in Table 2.1. Synthetic complete (SC) medium (6.7 
g/L yeast nitrogen base without amino acids, 20 g/L glucose, and 0.625 g/L complete 
supplement mixture (CSM) without leucine, tryptophan, and uracil) (Bio 101, Vista, CA) with 
appropriate nucleotides and amino acids was used for selection of the transformants. 
Cellobiose transport assay 
To determine the sensitivity of cellobiose transport by CDT-1 or CDT-2 to the strength of 
the plasma membrane proton gradient, strains expressing cdt-1 or cdt-2 were grown to OD600 
of 1.5 to 3.0 in selective media, washed three times with assay buffer (30 mM MES (2-(N-
morpholino) ethane sulfonic acid)-NaOH [pH 5.6] and 50 mM ethanol), and resuspended to an 
OD600 of 20 (Arendt et al. 2007). Then, 350 μL aliquots of cells were held on ice. To assay, the 
transport rate at a given concentration of carbonyl cyanide m-chlorophenyl hydrazine (CCCP), 
0.35 μL of a 1,000× CCCP stock made in 100 % ethanol was added to a single 350 μL aliquot 
of cells. This aliquot of cells was then incubated for 10 min in a room temperature water bath. 
After incubation, a transport assay was performed by adding 50 μL of cells to 50 μL of buffered 
[3H]-cellobiose with an appropriate concentration of CCCP that was layered above 100 μL of 
silicone oil. The same process was repeated sequentially for each tested concentration of 
CCCP. Controls with no CCCP were incubated for 10 min with 0.35 μL of 100 % ethanol. 
Fermentation experiments 
A single colony after transformation was picked and grown in YP medium (10 g/L yeast 
extract and 20 g/L peptone) with 20 g/L of cellobiose at 200 rpm and 30 °C to prepare inocula 
(L) for cellobiose fermentation experiments. Yeast cells at their mid-exponential phase were 
harvested by centrifugation and washed with sterilized water before inoculations. Fermentation 
experiments were performed in YP (10 g/L yeast extract and 20 g/L peptone) or SC (6.7 g/L of 
yeast nitrogen base, 0.42 g/L of Tween 80, and 0.01 g/L of ergosterol with CSM or without 
CSM, pH 6.0) media in an oxygen-limited condition or anoxic condition. Appropriate 
concentrations of cellobiose (20, 40, or 80 g/L) were used. Oxygen-limited fermentation 
experiments were performed in 25 mL culture using a 125 mL Erlenmeyer flask tightly covered 
by aluminum foil at 30 °C and an agitation speed of 100 rpm. Anaerobic fermentation was done 
by 20 mL culture using a 100-mL serum vial sealed with a rubber cap and nitrogen purged for 5 
min with gentle swirling. Vials were incubated at 30 °C at 100 rpm as well. Initial cell densities of 
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all fermentation experiments were adjusted to OD600 of 1. All fermentation experiments were 
performed in duplicates. 
Analytical methods 
Cell growth was monitored by measuring optical density at 600 nm using a UV-visible 
spectrophotometer (Biomate5, Thermo, Rochester, NY). Cellobiose, glycerol, acetate, ethanol, 
and cellodextrin concentrations were determined by high-performance liquid chromatography 
(Agilent Technologies 1200 Series, Mississauga, CA) equipped with a refractive index detector 
using a Rezex ROA-Organic Acid H+ (8 %) column (Phenomenex Inc., Torrance, CA). The 
column was eluted with 0.005 N of H2SO4 at a flow rate of 0.6 ml/min at 50 °C. 
 
2.3 Results  
Determination of a mode of transportation through cellobiose transport assay 
As observed in previous studies (Galazka et al. 2010), cellodextrin transporters in N. 
crassa (CDT-1 and CDT-2) with high affinity to cellobiose were selected for further 
characterization in S. cerevisiae. When the cellodextrin transporters were expressed with GH1-1 
in S. cerevisiae strains, the resulting engineered strains were able to utilize and grow with 
cellodextrin as the sole carbon source [41, 98]. 
To characterize the mechanism of transport by CDT-1 and CDT-2, their sensitivities to 
increasing concentrations of CCCP was measured. CCCP is a proton gradient uncoupler, which 
increases the proton permeability of the plasma membrane. The sensitivity of cellobiose 
transport by CDT-1 and CDT-2 to CCCP should, therefore, indicate whether or not either 
transporter utilizes the plasma membrane proton gradient during transport of cellobiose. S. 
cerevisiae YPH499 strains expressing cdt-1 or cdt-2 were incubated with different 
concentrations of CCCP and cellobiose transport rates were measured. As shown in Figure 2.1, 
the cellobiose transport rate of the S. cerevisiae strain expressing cdt-1 was reduced as CCCP 
concentration increased. However, the strains expressing cdt-2 showed a constant rate of 
cellobiose transportation regardless of CCCP concentrations. These results suggested that 




Comparison of cellobiose fermentation characteristics of engineered S. cerevisiae 
expressing CDT-1 and CDT-2 
CDT-1 and CDT-2 from N. crassa were further studied for the performance of cellobiose 
fermentation when they are co-expressed with GH1-1 in S. cerevisiae. Two strains (DBT-1 and 
DBT-2) overexpressing gh1-1 and cdt-1 or cdt-2 under the control of a strong constitutive 
promoter were developed. The resulting strains were then evaluated for their fermentation 
capability using cellobiose as a sole carbon source under various fermentation conditions. 
Cellobiose fermentation under oxygen-limited conditions 
Both the DBT-1 (with CDT-1) and DBT-2 (with CDT-2) strains were cultured in YP 
medium with 40 g/L of cellobiose under an oxygen-limited condition. As shown in Figure 2.2A, 
both strains were able to grow and ferment all 40 g/L of cellobiose and produce ethanol. 
However, the DBT-1G strain had a twofold faster growth and cellobiose consumption rate and 
about three to fivefold higher ethanol productivity when compared to the DBT-2 strain (Table 
2.2). Also, the DBT-1G strain was able to consume all cellobiose and reutilize cellodextrins 
(cellodextrins accumulate due to the transglycosylation activity GH1-1) within 36 h whereas the 
DBT-2 strain took about 72 h to utilize all cellodextrins. The DBT-1 strain correspondingly had a 
higher ethanol yield as compared to DBT-2 (Table 2.2; 0.42 g ethanol/g cellobiose vs. 0.31 g 
ethanol/g cellobiose). Interestingly, the DBT-2 produced 25% more biomass (OD600 = ~17 vs. 
OD600 = ~22) as compared to the DBT-1 strain at the end of fermentation, indicating that the 
DBT-2 strain directed more cellobiose consumption to yield biomass than the DBT-1 strain.  
Because transport assay data suggests that CDT-2 is a simple facilitator, I hypothesized 
that CDT-2 might work better when the cellobiose concentration is high. Therefore, cellobiose 
fermentation rates using 80 g/L of cellobiose were also examined (Figure 2.2B). However, 
similar fermentation profiles were observed as compared when 40 g/L of cellobiose was used. 
The DBT-1 still showed higher cellobiose consumption rate and produced ethanol with a higher 
yield than the DBT-2 strain. The DBT-1 consumed all cellobiose within 36 h and produced 
ethanol with a yield of 0.39 g ethanol/g cellobiose (Table 2.2) whereas the DBT-2 failed to utilize 
all of the cellobiose. The DBT-2 strains consumed only 60 g/L of cellobiose in 62 h and stopped 
using cellobiose when 20 g/L cellobiose and 25 g/L cellodextrin were left in the medium. Also, 
less biomass formation and ethanol production were observed in DBT-2 strain. 
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Because YP media is composed of many nutrients such as peptides and amino acids 
that can be used as a source for ATP generation in the cdt-1 expressing strain, cellobiose 
utilization of the strains expressing cdt-1 and cdt-2 along with gh1-1 in a minimal media were 
also examined (Figure 2.3). However, fermentation profiles in a minimal (SC) medium with 20 
g/L cellobiose were consistent with the profiles obtained from the YP media. The DBT-1 strain 
still showed a faster fermentation rate than the DBT-2 strain regardless of the media conditions. 
Furthermore, the DBT-2 strain was not able to consume all cellobiose in the minimal media and 
produced low amounts of ethanol even though a lower concentration of initial cellobiose was 
loaded. Notably, in minimal media conditions, the differences in fermentation rates between the 
two strains was exacerbated compared the case in YP media due to the fact that DBT-2 had 
much lower cellobiose consumption rate and almost no ethanol production. 
Cellobiose fermentation under anaerobic conditions 
In a parallel set of experiments, cellobiose fermentations by two strains under anaerobic 
conditions were also examined to investigate whether or not the minimized ATP synthesis that 
occurs under anaerobic conditions might affect cellobiose fermentation by the cdt-1 and cdt-2 
expressing strains. Both complex and minimal media was used for this comparison. Profiles of 
cellobiose fermentation of DBT-1 and DBT-2 under anaerobic conditions are illustrated in Figs. 
4 and 5. In the YP media with cellobiose concentrations (40 and 80 g/L; Figure 2.4), the DBT-1 
strain still had a significantly higher fermentation rate compared to the DBT-2 strain. In the 
minimal media (SC, with or without CSM) with 20 g/L cellobiose (Figure 2.5), the DBT-1 strain 
still showed a higher cellobiose fermentation rate and substantially more ethanol production.  
Taken together, the better cellobiose fermentation capability of the DBT-1 strain, when 
compared to the DBT-2 strain, was observed regardless of the fermentation conditions, resulting 
in both a higher yield and productivity for ethanol (Table 2.2). While CDT-2 may have energetic 
benefits, the expression levels and kinetic properties of CDT-2 in S. cerevisiae might not be 
optimum for cellobiose fermentation. These results suggest CDT-1 is a more effective cellobiose 
transporter than CDT-2 for engineering S. cerevisiae to ferment cellobiose. 
2.4 Discussion 
Traditionally, additional β-glucosidase prepared by extra fungal or bacterial fermentation 
has been added to allow efficient hydrolysis of cellulose to glucose. However, this may increase 
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the enzyme cost and risk of contamination by bacteria during the saccharification step. To 
overcome this problem, fungal cellobiose transporters and intracellular β-glucosidase were 
expressed in S. cerevisiae for direct fermentation of cellodextrins [41]. However, the detailed 
mechanisms and characteristics of these cellobiose transporters have not been investigated 
systematically. Among the cellobiose transporters discovered previously, CDT-1 or CDT-2 along 
with GH1-1 expressing strains were able to grow on cellobiose as a sole carbon source, and 
both transporters had a similar affinity (Km ≈ 3–4 μM) for cellobiose. However, the rates of 
cellobiose consumption were very different [41]. Hence, this study was undertaken to verify the 
difference between CDT-1 and CDT-2 in terms of energy (proton gradient) dependence and 
cellobiose fermentation characteristics under various cultivation conditions when they are 
overexpressed in S. cerevisiae. 
Generally, transport of a molecule across the plasma membrane can be mediated by 
two types of transporters: passive and active. Passive transport by a uniporter is driven only by 
the concentration gradient of the substrate, while active transport by a symporter (or antiporter) 
is also driven by the concentration of a second substrate. This second substrate is maintained 
out of equilibrium by the cell through an energy consuming process [99]. Some native 
transporters present in yeast, such as glucose transporters, transport glucose via facilitated 
diffusion [100]. On the other hand, yeast disaccharide transporters such as maltose and sucrose 
transporters transport substrates via active transport. Specifically, the maltose and sucrose 
transporters require the presence of a proton gradient to move their substrates across the 
membrane (proton symporter) [101, 102]. 
From the results of cellobiose transport assay, CDT-1 was concluded as a proton 
symporter and CDT-2 as a uniporter. This result suggests that the CDT-1 expressing strain may 
require more energy than the CDT-2 expressing strain during cellobiose fermentation. 
Consequently, I hypothesized that this difference in energy requirement would affect 
fermentation rates of these engineered strains. 
As YP media is composed of rich nutrients that can allow generation of excess energy, 
cannot exclude that the considerable difference in fermentation rates between the two strains 
may be because CDT-1 was reported to have a two-fold higher VMax than CDT-2 in a previous 
kinetic study [41]. Indeed, a faster fermentation rate was observed by DBT-1 in YP medium with 
40 g/L (or 80 g/L) cellobiose under oxygen-limited conditions (Figure 2.2). In addition, I 
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anticipated that the DBT-2 might show an increased fermentation rate with an increased initial 
concentration of cellobiose (40 to 80 g/L); however, slower cellobiose consumption, less 
production of ethanol, and much higher accumulation of cellodextrin were observed in the DBT-
2 fermentation with 80 g/L of cellobiose (Figure 2.2).  This result is likely due to increased levels 
of intracellular cellobiose leads to transglycosylation of cellobiose in cellodextrins by GH1-1 
rather than degradation to glucose. The transglycosylation reaction of GH1-1 occurs under 
kinetically controlled conditions; therefore, an increased level of intracellular cellobiose will favor 
formation of cellodextrin accumulation intracellularly [103, 104], along with some secretion via 
the transporters. It is also possible that, although GH1-1 was expressed intracellularly, a very 
small amount of GH1-1 might be secreted out via nonconventional protein secretion pathway 
[105, 106]. A previous study on fungal β-glucosidase suggests a small amount of GH1-1 can 
have transglycosylation activity with a high concentration of the substrate [47]. Thus, a small 
amount of GH1-1 secretion could result in significant cellodextrin accumulation. This explains 
why DBT-1 accumulated less cellodextrin than DBT-2. Because CDT-1 was reported to have 
higher VMax for cellodextrin (cellotriose and cellotetraose) than CDT-2 [41], DBT-1 can re-
assimilate cellodextrin faster than DBT-2. 
I speculated that a similar or even better fermentation rate by the DBT-2 rather than the 
DBT-1 strain would occur if the fermentation was performed with the minimal medium because 
nutrients for energy generation can be limited in minimal media conditions. However, the DBT-2 
strain showed the same pattern of fermentation profile as in YP media (Figure 2.3), and the 
DBT-1 strain was still more efficient for fermenting cellobiose than the DBT-2 strain. Under 
minimal media condition, there was negligible amount cellodextrin accumulation (<1 g/L; Figure 
2.3). This result is consistent with the previous study on cellodextrin transporters [41] where no 
secretion of GH1-1 was confirmed under minimal media. It is possible that the leakage of GH1-1 
occurs under certain culture conditions, such as complex media. Regardless of the cellodextrin 
accumulation mechanism, CDT-1 is more effective in transporting cellobiose in the presence of 
oxygen regardless of the nutrient availability. 
In addition to nutrient availability, the presence of oxygen was also expected to influence 
the fermentation profile. Under the anaerobic condition, the TCA cycle will be fully inactivated, 
and ATP generation is limited, and I reasoned that CDT-1 expressing cells might not produce 
enough energy to maintain active transport of cellobiose [107]. However, overall, there was no 
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significant difference in the fermentation profile pattern of the two strains under anaerobic 
conditions. Again, the CDT-1 expressing strain showed faster cellobiose fermentation as 
compared to the CDT-2 expressing strain. These results show that CDT-1 mediates more 
efficient cellobiose transport, which in turn results in a higher yield and productivity than CDT-2 
regardless of nutrient and oxygen availability. As the previous study indicates, both CDT-1 and 
CDT-2 had a high affinity to cellobiose, but CDT-1 had a higher VMax. Superior cellobiose 
fermentation by strains expressing CDT-1 may be due to the VMax difference in CDT-1 and CDT-
2. 
In conclusion, cellodextrin transporters (cdt-1 and cdt-2) and intracellular ß-glucosidase 
(gh1-1) from N. crassa were introduced into S. cerevisiae. By introducing each cdt-1 and cdt-2 
paired with ß-glucosidase, both engineered strains (DBT-1 and DBT-2) were able to utilize 
cellobiose as a sole carbon source and produce ethanol. The DBT-1 strain showed a more 
efficient cellobiose fermentation as compared to the DBT-2 strain regardless of oxygen levels 
and media conditions. This is likely to due to the VMax difference between CDT-1 and CDT-2. It 
will be interesting to determine if the transport rate of CDT-2 may be improved through various 
engineering techniques and if this improvement may subsequently provide the dual advantages 








2.5 Figures and tables  
 
 
Figure 2.1 Sensitivity of cellobiose transport by CDT­1 and CDT­2 to the proton uncoupler, 
carbonyl cyanide m­chlorophenyl hydrazine (CCCP). S. cerevisiae strains expressing CDT-1 
(closed circle) or CDT-2 (open circle) were incubated with the indicated concentration of CCCP 
for 10 minutes at room temperature. Then the rate at which these cells imported 0.25 μM [3H]-
cellobiose was measured. The dashed line indicates the rate of transport by S. cerevisiae 






Figure 2.2 Fermentation profile comparisons between S. cerevisiae D452-2 gh1-1 and cdt-1 or 
cdt-2 (DBT-1 and DBT-2, respectively) with rich media conditions and under oxygen-limited 
condition. Growth, cellobiose consumption, ethanol production and cellodextrin accumulations 
were compared as presented on the first, second and third column, respectively. (A) 
Fermentation profile under YP medium with 40 g/L cellobiose. (B) Fermentation profile under YP 
medium with 80 g/L cellobiose. Symbols: DBT-1 strain (black) DBT-2 (white), growth (circle), 





Figure 2.3 Fermentation profile comparisons between S. cerevisiae DBT-1 and DBT-2 with 
minimal medium and under oxygen-limited conditions. Growth, cellobiose consumption, ethanol 
production and cellodextrin accumulations were compared as presented in the first, second and 
third columns, respectively. (A) Fermentation profile under SC and CSM supplemented medium 
with 20 g/L cellobiose. (B) Fermentation profile under SC medium with 20 g/L cellobiose. 
Symbols: DBT-1 strain (black) DBT-2 strain (white), growth (circle), cellobiose (triangle), ethanol 





Figure 2.4 Fermentation profile comparisons between S. cerevisiae DBT-1 and DBT-2 with rich 
medium and under anaerobic conditions. Growth, cellobiose consumption, ethanol production 
and cellodextrin accumulations were compared as presented on the first, second and third 
column, respectively. (A) Fermentation profile under YP medium with 40 g/L cellobiose. (B) 
Fermentation profile under YP medium with 80 g/L cellobiose. Symbols: DBT-1 strain (black) 









Figure 2.5 Fermentation profile comparisons between S. cerevisiae DBT-1 and DBT-2 with 
minimal medium and under anaerobic conditions. Growth, cellobiose consumption, ethanol 
production and cellodextrin accumulations were compared as presented in the first, second and 
third columns, respectively. (A) Fermentation profile under SC and CSM supplemented medium 
with 20 g/L cellobiose. (B) Fermentation profile under SC medium with 20 g/L cellobiose. 
Symbols: DBT-1 strain (black) DBT-2 strain (white), growth (circle), cellobiose (triangle), ethanol 




Table 2.1 The list of plasmids and S. cerevisiae strains used in this study 
Plasmids and 
strains Relevant features 
Sources and 
references 
Plasmids   
pRS425PGK LEU2, PPGK -MCS- TCYC,  2μ origin, Ampr [41] 
pRS426PGK URA3, PPGK -MCS- TCYC,  2μ origin, Ampr [41] 
pRS425-gh1-1 LEU2, PPGK-gh1-1-TCYC, 2μ origin, Ampr [41] 
pRS426-cdt-1 URA3, PPGK-cdt-2-TCYC, 2μ origin, Ampr [41] 
pRS426-cdt-2 URA3, PPGK-cdt-1-TCYC, 2μ origin, Ampr [41] 
Strains   
YPH499 MATa ura3-52 lys2-801_amber ade2-101_ochre trp1-Δhis3-Δ200 leu2-Δ1 [96] 
D452-2 MATα leu2 his3 ura3 can1 [97] 
DBT-1 D452-2/ pRS425-gh1-1/pRS426-cdt-1 This study 





Table 2.2 Fermentation parameters of DCDT-1G and DCDT-2G under various media conditions 
and in oxygen-limited or anaerobic conditions 




DBT-1 0.42 ± 0.00 0.46 ± 000 0.73 ± 0.02 
DBT-2 0.31 ± 0.00 0.14 ± 0.00 0.17 ± 0.01 
YPC804) 
DBT-1 0.39± 0.01 0.53± 0.01 0.39 ± 0.55 
DBT-2 0.19± 0.00 0.11± 0.00 15.3 ± 0.65 
SCC20 w/ CSM5) 
DBT-1 0.39± 0.00 0.13± 0.00 0.63 ± 0.00 
DBT-2 0.23± 0.02 0.34± 0.00 10.5 ± 0.62 
SCC20 w/o CSM6) 
DBT-1 0.37± 0.00 0.13± 0.00 0.60 ± 0.00 
DBT-2 0.23± 0.03 0.03± 0.00 12.3 ± 0.09 
Anaerobic 
YPC40 
DBT-1 0.43± 0.01 0.35± 0.01 0.83 ± 0.00 
DBT-2 0.36± 0.00 0.09± 0.00 0.56 ± 0.16 
YPC80 
DBT-1 0.42± 0.01 0.41± 0.02 0.35± 0.50 
DBT-2 0.28± 0.00 0.13± 0.00 11.7 ± 0.46 
SCC20 w/ CSM 
DBT-1 0.49± 0.01 0.17± 0.00 0.71 ± 0.00 
DBT-2 0.48± 0.00 0.05± 0.00 13.1 ± 0.06 
SCC20 w/o CSM 
DBT-1 0.47± 0.00 0.16± 0.00 0.61 ± 0.00 
DBT-2 0.45± 0.05 0.05± 0.01 12.5 ± 0.07 
1)Fermentation parameters: YEtOH, ethanol yield (g ethanol g sugars-1), PEtOH, ethanol productivity 
(g ethanol L-1 h-1). 
2)Residual cellobiose concentration (g/L) at the end of fermentation. 
3)YP medium containing 40 g/L of cellobiose, calculated at the end of fermentation. 




CHAPTER III: Enhanced Cellobiose Fermentation by Engineered Saccharomyces 
cerevisiae Expressing a Mutant Cellodextrin Facilitator and Cellobiose Phosphorylase 2 
 
3.1 Introduction 
There have been extensive efforts to engineer microorganisms to produce fuels and 
chemicals from renewable cellulosic biomass mainly composed of polymers of glucose and 
xylose [91]. Saccharomyces cerevisiae, a preferred industrial yeast to produce biofuels and 
chemicals, has been engineered for efficient fermentation of xylose [27, 36, 39, 108-110]. 
However, xylose cannot be consumed in the presence of glucose due to glucose repression. 
Thus, yeast will sequentially utilize glucose first then xylose during mixed sugar fermentation 
with low ethanol yield and productivity [72, 111]. 
To overcome sequential sugar utilization and increase the efficiency of the fermentation, 
cellobiose, a dimer of glucose linked by β-(1→4) bonds [112], has been noted as an alternative 
sugar to glucose [41, 45, 46, 113]. Previous studies demonstrated that cellobiose and xylose 
could be simultaneously utilized due to the absence of glucose catabolite repression. Therefore, 
overall ethanol yield and productivity was dramatically improved by co-fermentation of 
cellobiose and xylose compared to diauxic utilization of glucose and xylose [24, 98]. 
Researchers note that heterologous expression of a cellodextrin transporter and an 
intracellular cellobiose hydrolyzing enzyme is essential for S. cerevisiae to ferment cellobiose 
[41, 44, 46]. Previous studies identified cellodextrin transporters from Neurospora crassa, CDT-
1 or CDT-2 coupled with a hydrolytic enzyme (intracellular β-glucosidase from N. crassa) or 
phosphorolytic enzyme (cellobiose phosphorylase from Saccharophagus degradans) can be 
introduced to S. cerevisiae for cellobiose fermentation [43, 45, 114]. Thus, four different types of 
cellobiose utilization can be available in engineered S. cerevisiae (Fig. 1). Cellobiose is 
transported across the membrane by either CDT-1 (active transporter consuming one ATP per 
cellobiose) or CDT-2 (energy-independent facilitator) [43]. Once cellobiose enters the cell, it can 
be cleaved by hydrolysis with intracellular β-glucosidase (GH1-1) or phosphorolysis with 
cellobiose phosphorylase (CBP). When cellobiose is cleaved by β-glucosidase, two moles of 





glucose are generated and subsequently converted to two moles of glucose-6-phosphate by 
hexokinases with the expense of two moles of ATP. On the other hand, phosphorolysis 
generates one mole of glucose and one mole of glucose-1-phosphate, saving one mole of ATP 
as glucose-1-phosphate is simply isomerized to glucose-6-phosphate by phosphoglucomutase 
without spending ATP [45, 115]). Consequently, the yeast expressing CDT-1 and β-glucosidase 
spends more energy (2 moles of ATP) than the yeast expressing CDT- 2 and cellobiose 
phosphorylase when grown on cellobiose, which suggests that CDT-2 paired with cellobiose 
phosphorylase can provide energetic benefits to yeast during industrial scale fermentation as 
many stress-overcoming cellular processes require ATP. Additionally, strains expressing 
cellobiose phosphorylase do not accumulate cellodextrin whereas strains expressing β-
glucosidase showed accumulation of significant amounts of extracellular cellodextrin that has 
caused inefficient cellobiose fermentation and reduction of ethanol productivity [43, 45]. 
However, we previously observed yeast expressing CDT-2 could not perform efficient 
cellobiose utilization compared with yeast expressing CDT-1 (Kim et al. 2014). Thus, this study 
was undertaken to improve transporting activity of CDT-2 via evolutionary engineering [74]. We 
imposed cellobiose as a selection pressure onto yeast expressing CDT-2 and the cellobiose 
phosphorylase. After nine rounds of serial subcultures on cellobiose, we isolated an evolved 
strain exhibiting significantly faster cellobiose assimilation and increased ethanol yields. Also, 
we report that change of single amino acid residue on CDT-2 is sufficient for drastic 
improvement of cellobiose utilization in engineered S. cerevisiae. 
 
3.2 Materials and methods 
Strains and plasmids  
All strains and plasmids used in the study are listed in Table 3.1. Cellobiose transporter 
genes from N. crassa FGSC 2489, NCU 00801 (cdt-1) and NCU08114 (cdt-2) were cloned into 
a pRS426 plasmid (URA3, PGK1 promoter, and CYC1 transcriptional terminator), respectively. 
An intracellular β-glucosidase gene (gh1-1) from N. crassa was cloned into a pRS425 plasmid 
(LEU2, PGK1 promoter, CYC1 transcriptional terminator) [41]. A cellobiose phosphorylase gene 
(SdCBP) from Saccharophagus degradans was cloned into a pRS425 plasmid (LEU2, PGK1 
promoter, CYC1 transcriptional terminator) [45]. To create gfp tagged CDT-2 transporter, gfp 
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gene was cloned into pRS426 cdt-2.  S. cerevisiae D452-2 (MATα leu2 his3 ura3 can1) [97] 
was used for transformation of the plasmids and characterization of the cellobiose fermentation.  
Synthetic complete (SCD) medium (6.7 g/L yeast nitrogen base without amino acids, 20 g/L 
glucose and 0.625 g/L complete supplement mixture (CSM) without leucine, tryptophan and 
uracil) (Bio 101, Vista, CA) with appropriate nucleotides and amino acids was used for selection 
of the transformants. 
Cellobiose fermentation experiments 
A single colony after transformation was picked and grown in YP medium (10 g/L yeast 
extract and 20 g/L peptone) with 20 g/L of cellobiose at 250 rpm and 30°C to prepare inocula for 
fermentation experiments. Yeast cells at mid-exponential phase were harvested by 
centrifugation and washed with sterile water before inoculations. Fermentation experiments 
were performed in YP (10 g/L yeast extract and 20 g/L peptone) with 80 g/L of cellobiose in 
micro-aerobic condition or anaerobic condition. Micro-aerobic fermentation experiments were 
performed in 25 mL culture using a 125 mL Erlenmeyer flask tightly covered by aluminum foil at 
30°C and 100 rpm. Anaerobic fermentation was performed by 20 mL culture using a 100-mL 
serum vial sealed with a rubber cap and nitrogen purged for 15 min with gentle swirling. Vials 
were incubated at 30 °C at 100 rpm as well.  Initial cell densities of all fermentation experiments 
were adjusted to an OD600 of 1. All fermentation experiments were performed in duplicates. 
Laboratory evolution and isolation of an evolved strain 
For laboratory evolution, serial subcultures on cellobiose were conducted with an S. 
cerevisiae strain harboring pRS425 cdt-2 and pRS426 SdCBP.  Yeast inoculum was prepared 
by cultivating a single colony in 5mL YP medium with 20 g/L of cellobiose at 30°C and 250 rpm.  
Cells were harvested, and an initial cell density equal to an OD600 of 1 was inoculated in 25 mL 
of YP medium with 80 g/L of cellobiose using 125 mL Erlenmeyer flasks.  When cellobiose 
concentration reached below 10 g/L, inoculum equivalent to an OD600 of 1 was collected and 
transferred to a new 25mL of YP medium with 80 g/L cellobiose.  This step was repeated nine 
times, and a single colony from the culture was isolated. A single colony isolated was then 




Cell growth was monitored by measuring optical density (OD) at 600 nm using a UV-
visible spectrophotometer (Biomate5, Thermo, Rochester, NY). Cellobiose, cellodextrin, and 
ethanol concentrations were determined by high-performance liquid chromatography (HPLC, 
Agilent Technologies 1200 Series, Mississauga, CA) equipped with a refractive index detector 
using a Rezex ROA-Organic Acid H+ (8%) column (Phenomenex Inc., Torrance, CA). The 
column was eluted with 0.005 N of H2SO4 at a flow rate of 0.6 ml/min at 50°C. 
Transporter topology prediction of CDT-2 
Homology model of CDT-2 was predicted by online web portal server Phyre2 
(http://www.sbg.bio.ic.ac.uk/phyre2)[116] using intensive mode. 90% of the residues were 
modeled with >90% accuracy. Then VMD (Visual Molecular Dynamics, 
http://www.ks.uiuc.edu/Research/vmd/, [117]) program was used to visualize the resulting 
homology model (PDB entry 4GBZ).  
Fluorescence measurement and intracellular cellobiose measurement 
To measure fluorescence of gfp tagged transporters, S. cerevisiae harboring pRS425 
cdt-2-gfp or pRS425 cdt-2 N306I-gfp were cultured in SCD medium without uracil at 30°C and 
250 rpm. Cells were harvested at the late exponential phase and washed twice with sterile 
water.  Cell density equal to an OD600 5 were re-suspended in 300 µL of sterile water and 
transferred to a black 96 well plate for fluorescence measurement. To measure intracellular 
cellobiose, cells cultured in SCD medium without uracil were harvested at mid-exponential 
phase.  Cells were washed twice with sterile water, transferred to YPC 20g/L medium and 
incubated at 30°C and 250 rpm. Cells were harvested by centrifugation and washed twice with 
ice-cold water at 15 hours of incubation which showed cellobiose concentration of both CDT-2 
and CDT-2m expressing strain. Cell density equal to an OD600 30 were re-suspended in 1 mL of 
< 40°C methanol with glass beads. After a vigorous vortexing for 3 minutes, samples were 
incubated in -80°C for 30 minutes. Supernatants were separated by centrifugation, and 900 µL 
were transferred to a microcentrifuge tube and allowed to evaporate. Then remaining solids 





Comparison of cellobiose fermentation by engineered yeast with CDT-1 and CDT-2 
coupled with phosphorylase 
As I hypothesized that CDT-2 paired with SdCBP might have energetic benefits during 
fermentation, two yeast strains overexpressing cdt-1 with SdCBP (DCT-1) and cdt-2 with 
SdCBP (DCT-2) were compared for cellobiose fermentation capability under oxygen-limited 
conditions. As shown in Figure 3.2, both strains could grow on 80 g/L of cellobiose. As 
expected, cellodextrin accumulation was not observed in both DCT-1 and DCT-2 strains. 
However, DCT-2 showed poorer growth rate, cellobiose consumption and ethanol production 
compared to DCT-1. Because similar cellobiose fermentation patterns were already observed in 
yeast strains expressing CDT-1 and CDT-2 coupled with GH1-1 [43, 118], in general, CDT-2 is 
an inefficient cellobiose transporter regardless of pairing with hydrolytic or phosphorolytic 
enzymes. 
Laboratory evolution of strain DCT-2 for improved cellobiose fermentation 
To improve CDT-2 performance on cellobiose transportation, I performed serial 
subculture of DCT-2 with cellobiose.  In this case, cellobiose is not only the major carbon source 
but also a selection pressure: the cells with beneficial mutations on cellobiose metabolism will 
become dominant during serial subculturing. Initially, cell inoculum equivalent to OD 1 was 
inoculated to YPC 80 g/L medium. Once cell growth was observed and cellobiose consumption 
was observed but before depleted, cell inoculum equivalent to OD 1 was transferred to fresh 
YPC 80 g/L media. I repeated subculturing successively as cellobiose utilization rate improved 
gradually and stopped when cellobiose utilization rate improvement ceased (total nine rounds of 
serial subculture on cellobiose). Then, single colonies from the last culture were isolated, and 
fermentation capability was compared with an original DCT-2 strain to confirm the improvement. 
As shown in Figure 3.3, all three isolated colonies from the evolved DCT-2 culture showed 
consistent and significant improvement in cellobiose fermentation compared to the original DCT-
2 strain. While the original DCT-2 could not finish consuming cellobiose at 120 hours, three 
evolved colonies were able to complete fermenting all cellobiose within 36 hours with 
corresponding improvements in ethanol productivities.  
A single nucleotide change in cdt-2 for improved cellobiose fermentation 
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To confirm whether mutations formed in either CDT-2 or SdCBP during serial subculture, 
both plasmids were rescued from all three isolates and sequenced along with wild-type CDT-2 
and wild-type SdCBP plasmids. While no change of DNA sequence was observed on the 
rescued SdCBP, one mutation was observed on the all three rescued CDT-2.  Base pair 
adenine was changed to thymine at position 917 (A917T), resulting in a change of protein 
sequence from asparagine to isoleucine at position 306 of CDT-2 (N306I) (Figure 3.4). To 
analyze the potential effects of this mutation, I predicted the structure of CDT-2 using the 
Phyre2 web portal [116]. The Phyre2 analysis used 20 templates that had 100% confidence of 
CDT-2 sequence covering protein sequence 14-525. Then, the mutant CDT-2 homology model 
was structurally aligned to E. coli XylE, xylose proton symporter bound to glucose (PDB entry 
4GBZ, total 462 nucleotide alignment to CDT2) as other previous cellobiose transporter studies 
[119, 120]. As shown in Figure 3.4, mutation N309I occurred within a transmembrane α-helix 
domain. (Figure 3.4A). A mutation at such a location might enhance the cellobiose uptake rate 
of CDT-2 as observed in the previous report [118]. To examine if the N306I mutation influenced 
the expression level of the mutated CDT-2, expression levels of wild-type and mutant CDT-2 
were monitored by tagging with GFP and measuring fluorescence (Figure 3.4B). Mutant CDT-2 
showed about 2-fold higher fluorescence than wild-type CDT-2, indicating mutation increases 
expression level or stability of CDT-2. Next, yeast strains with only expressing CDT-2 and 
mutated CDT-2 (N309I) were incubated in YPC 20g/L medium to observe relative cellobiose 
transport activities. I observed intracellular cellobiose accumulation at 15h based where both 
CDT-2 and CDT-2m shows detectable and comparable cellobiose transportation. As expected, 
the engineered yeast expressing the N309I CDT-2 showed ~6 times higher intracellular 
cellobiose accumulation than the engineered yeast expressing CDT-2. These results confirm 
that the N309I mutation in CDT-2 may enhance expression and overall enhanced transporting 
capability in yeast (Figure 3.4C). 
Comparison of phosphorolytic and hydrolytic pathways for cellobiose fermentation  
After identifying the beneficial mutation (N309I) on CDT-2, I introduced the mutant CDT-
2 into a wild-type S. cerevisiae along with SdCBP to verify that such an improvement of 
cellobiose fermentation is due solely to a mutation on cellodextrin transporter and not a genomic 
mutation in the yeast. As shown in Figure 3.5, the transformant expressing the mutant CDT-2 
and SdCBP (DCT-2m) was able to consume cellobiose as fast as isolates from the serial 
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subculture (Figure 3.4B and C), suggesting that the single amino acid mutation on CDT-2 is to 
responsible for enhanced cellobiose fermentation capacity. 
I suspected that the mutant CDT-2 might also improve cellobiose fermentation when 
paired with intracellular β-glucosidase. Thus, the mutant CDT-2 and GH1-1 genes were 
introduced into wild-type S. cerevisiae to enable cellobiose fermentation by the hydrolytic 
pathway (Figure 3.1). To compare fermentation capabilities of yeast the phosphorolytic pathway 
(yeast expressing CDT-2m and SdCBP; DCT-2m with yeast utilizing the hydrolytic pathway 
(yeast expressing CDT-2m and GH1-1; DBT-2m), DCT-2m and DBT-2m strains were cultured in 
YPC 80 g/L medium under oxygen-limited conditions. The DCT-2m strain was able to ferment 
cellobiose and produce ethanol at a faster rate than DBT-2m (Figure 3.5). While strain DCT-2m 
was able to completely consume 80 g/L of cellobiose within 48h without any accumulation of 
cellodextrin, strain DBT-2m consumed all cellobiose within 60h while accumulating significant 
amounts of cellodextrin (Figure 3.5D). Strain DCT-2m showed higher ethanol yield and 
productivity from cellobiose than strain DBT-2m (0.42 g/g ethanol yield and 0.70 g/L·h by the 
DCT-2m strain vs. 0.32 g/g ethanol yield and 0.36 g/L·h by DBT-2m strain, Table 3.2, second 
column).  
To further validate the superiority of strain, I performed cellobiose fermentation (YPC 80 
g/L) under the anaerobic condition where energy generation is limited. At the end of 
fermentation, ethanol yield and productivities were calculated (Table 3.2, third column). In 
general, all strains tested had slower cellobiose fermentation rate. DCT-2m strain highest 
ethanol yield (0.45 g/g) compared to DCT-1, DCT-2, DBT-2 and DBT-2m (0.44 g/g, 0.39 g/g, 
0.29 g/g and 0.32 g/g, respectively. For ethanol productivity, however, DBT-2m produced 
ethanol at a higher rate compared to DCT-2m strain (0.21 g/L·h vs. 0.11 g/L·h). Still, DBT-2m 
had significantly lower ethanol yield (0.32 g/g) due to cellodextrin accumulation. Under 
anaerobic fermentation, β-glucosidase expressing strains (DBT-2 and DBT-2m) was not able to 
re-assimilate cellodextrin (data not shown). 
  
3.4 Discussion 
Fermentation of cellobiose (or cello-oligosaccharides from enzymatic cellulose 
hydrolysis) by engineered yeast has received strong attention as a promising strategy to replace 
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current corn starch fermentation. Heterologous expression of cellodextrin transporters and 
intracellular cellobiose hydrolyzing enzymes are necessary for S. cerevisiae to ferment 
cellobiose. Thus, previous reports identified several cellodextrin transporters and hydrolyzing 
enzymes from a variety of microorganism. Particularly, two cellodextrin transporters (CDT-1 and 
CDT-2) from N. crassa and two cellobiose hydrolyzing enzymes (GH1-1 from N. crassa and 
SdCBP from S. degradans) have been functionally expressed in yeast, leading to not only direct 
fermentation of cellobiose, but also co-fermentation of mixed sugars such as cellobiose/xylose 
and cellobiose/galactose [24, 44, 121]. Among the two cellodextrin transporters, yeast strains 
expressing CDT-1 showed better cellobiose fermentation than yeast strains expressing CDT-2 
when paired with β-glucosidase [43]. I reason that the difference in cellobiose fermentation rate 
might be caused by different kinetic properties of CDT-1 and CDT-2. CDT-1 exhibits 2-fold 
higher Vmax than CDT-2 while Michaelis constant (Km) remains slightly higher than CDT-2 (4.0 
µM vs. 3.2 µM). (Galazka et al. 2010). Also, CDT-1 is an active transporter requiring ATP to 
transport even low concentrations of cellobiose, but CDT-2 is a facilitator which depends on a 
cellobiose concentration gradient. While engineered yeast expressing CDT-1 showed faster 
cellobiose fermentation than engineered yeast expressing CDT-2, expression of CDT-2 in yeast 
might be more advantageous for large-scale production of ethanol because most industrial 
fermentations are performed under harsh conditions (i.e., ATP-limited conditions) caused by 
pretreatment of cellulosic biomass with acids or bases.  
Despite the potential advantage of CDT-2, it is necessary to improve kinetic properties of 
CDT-2 for feasible cellobiose fermentation due to slower cellobiose fermentation compared to 
CDT-1. There have been efforts to improve the kinetic properties of CDT-2 through protein 
engineering and identification of mutants presenting enhanced cellobiose fermentation when 
paired with GH1-1 [118]. However, GH1-1 frequently causes the formation of undesirable by-
products such as cellodextrin (a by-product from transglycosylation by β-glucosidase), resulting 
in inefficient cellobiose fermentation. Indeed, previous reports showed that accumulation of 
cellodextrins by the strains expressing intracellular β-glucosidase yielded less ethanol 
regardless of the type of transporter [43, 45]. As an alternative to β-glucosidase, cellobiose 
phosphorylase can be used to eliminate cellodextrin accumulation. Additionally, the 
phosphorolysis of cellobiose reaction will consume one less ATP per one cellobiose compared 
to the hydrolysis reaction.  However, the catalysis by cellobiose phosphorylase is a 
thermodynamically unfavorable reaction (ΔG > 0), contributing to inefficient cellobiose 
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fermentation by yeast strains expressing SdCBP compared with strains expressing GH1-1. To 
observe cellobiose fermentation pattern by DCT-2 in S. cerevisiae, fermentation experiments 
were conducted in YPC 80 g/L medium and under microaerobic condition. As a result, CDT-2 
and SdCBP combination had the least efficient cellobiose fermentation compared to other 
transporter and hydrolyzing enzyme despite its potential advantages ([43], Figure 3.1). Thus, I 
hypothesized improvement of DCT-2 is necessary to benefit the potential energetic advantages 
of CDT-2 and SdCBP.  
Previous studies show that kinetic properties of cellodextrin transporters were drastically 
changed by mutated cellodextrin transporters, thus an improvement on cellobiose fermentation 
[45]. Also, the mutated cellodextrin transporters have been obtained through laboratory 
evolution of yeast strains expressing cellodextrin transporters such as CDT-1 from N. crassa 
and HXT2.4 from Pichia stipitis [42, 118]. As such, I reasoned that transporting activity of CDT-2 
might also be improved by modification of some amino acid residues on CDT-2, which would 
lead to enhanced cellobiose fermentation rate in engineered S. cerevisiae.  
Based on the previous successes with laboratory evolution engineering approach, a 
similar strategy was adapted to improving DCT-2 strain, evolving under cellobiose-containing 
media. I hypothesized a significant selection pressure could stimulate the rate of cellobiose 
fermentation with 80 g/L of cellobiose in the media. From nine rounds of evolution, I identified a 
mutant CDT-2 (N306I) sufficient to significantly improve the rate of cellobiose fermentation and 
yield of ethanol. To visualize the single mutation on the protein structure, CDT-2 (N306I) 
homology model was created using Phyre2 and structurally aligning to E. coli XylE bound to 
glucose. From the alignment result, the local region of N306I mutation (Figure 3.4, left arrow) 
was located near the vicinity of the substrate binding site N294 of XylE (Figure 3.4, right arrow), 
possibly in the binding site for a substrate unit. Also, as a result of the mutation N306I, overall 
expression or stability and cellobiose transportation may have enhanced (Figure 3.4B and C).  
I confirmed the beneficial effect of the mutant CDT-2 by re-constructing strain DCT-2m 
and fermenting 80 g/L of cellobiose under oxygen-limited conditions. Indeed, DCT-2m could 
consume cellobiose and produce ethanol at a faster rate and higher yield than both DCT-1 and 
DCT-2. In the most favorable condition, the ethanol yield and productivity of DCT-2m were 
approximately 2-fold and 10-fold higher than DCT-2, respectively (Table 3.2). When considering 
directed evolution of CDT-2 improved expression level as well as cellobiose uptake activity 
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(Figure 3.5), change of the kinetic properties, increase in the expression level, or enhanced the 
stability of mutant CDT-2 may explain the enhanced cellobiose fermentation of DCT-2m 
observed in this study.  
I also investigated whether expression of the mutant CDT-2 with β-glucosidase in a wild-
type yeast could also increase the rate of cellobiose consumption and ethanol yield. However, 
we did not observe a significant improvement of cellobiose consumption rate and ethanol yield 
in yeast expressing the mutant CDT-2 with GH1-1 as observed with yeast expressing the 
mutant CDT-2 with SdCBP. While DCT-2m showed 100% and 900% enhanced ethanol yield 
and productivity than DCT-2, DBT-2m showed 70% and 230% changes in ethanol yield and 
productivity than DBT-2. This effect may be caused by the incapability for mutant CDT-2 to 
transport cellodextrins formed by transglycosylation activity of GH1-1 as observed in the 
previous study [43] and shown in Fig. 3.5. Most likely, improvement of cellobiose fermentation in 
DBT-2m may be due to increased expression level, stability, and kinetic properties change 
specific to cellobiose but not cellodextrins. Correspondingly, DCT-2m, a strain which does not 
accumulate cellodextrins, showed enhanced performance in cellobiose fermentation and 
produced more ethanol at a faster rate than DBT-2m (0.42 g/g and 0.70 g/L· h in DCT-2m vs. 
0.33 g/g and 0.36 g/L· h in DBT-2m). Additionally, cellodextrin accumulation is likely to require 
more ATP for re-assimilation, resulting in residual cellodextrin at the end of fermentation (Fig. 
3.5D).  
I further hypothesized that the energetic benefits of CDT-2 requiring less ATP might 
become maximized under energy-limited conditions. Anaerobic condition limits respiration of the 
yeast strains thus limit energy production. DCT-1, DCT-2, DCT-2m, DBT-2 and DBT-2m were 
compared for anaerobic cellobiose fermentation regarding ethanol yield and productivities 
(Table 3.2, third column). Like micro-aerobic condition, strains expressing CDT-2m showed 
improvement in cellobiose fermentation. Among all strains tested, the DCT-2m strain had the 
highest ethanol yield of the strains compared, even compared to micro-aerobic condition (0.45 
g/g vs. 0.44 g/g). However, under anaerobic condition, I observed DBT-2m strains exhibited 
higher ethanol productivities but lower yield than DCT-2m strain (0.21 g/L· h vs. 0.11 g/L· h for 
productivity and 0.32 g/g vs. 0.45 g/g for yield). As mentioned above, it is likely due to efficient 
cellobiose conversion by GH1-1 but the accumulation of cellodextrin by trans-glycosylation 
activity. Under anaerobic condition, re-assimilation of cellodextrin might be even more 
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challenging due to limited energy production. In sum, improved cellobiose fermentation was only 
observed with strains expressing CDT-2m compared to CDT-2 regardless of the which 
hydrolyzing enzyme it is paired with. DCT-2m (CDT-2m with phosphorylase) showed the most 
efficient utilization of cellobiose especially under microaerobic cellobiose fermentation, proven 
by its ethanol yield and productivity. 
In conclusion, the introduction of a mutated energy independent cellodextrin transporter 
(CDT-2) from N. crassa and cellobiose phosphorylase (SdCBP) from S. degradans into S. 
cerevisiae resulted in the fermentation of cellobiose as the sole carbon source without 
cellodextrin accumulation. An original strain expressing CDT-2 showed very inefficient 
cellobiose fermentation. However, a single nucleotide change in CDT-2 could improve the 
cellobiose fermentation significantly. Our mutant CDT-2 paired with phosphorylase may provide 
several advantages in the fermentation of cellulosic biomass by allowing energy conservation 
and better fermentation parameters. 





Figure 3.1 Possible cellobiose fermentation pathways with the combinatorial introduction of 
cellobiose transporters and cellobiose cleaving enzymes. Either Cdt-1 or Cdt-2 transport 
cellobiose across the membrane; then cellobiose is cleaved by either hydrolytic enzyme 
(intracellular β-glucosidase, GH1-1) or phosphorolytic enzyme (cellobiose phosphorylase, 
SdCBP). Cleaved cellobiose, generating two glucose or one glucose with one glucose-1-
phosphate, is converted to glucose-6-phosphate via hexokinases (HXKs) and 






Figure 3.2 Comparison of fermentation profiles between S. cerevisiae DCT-1 expressing cdt-1 
and SdCBP and S. cerevisiae DCT-2 expressing cdt-2 and SdCBP in YP media under oxygen-
limited conditions. Cell growth (A), cellobiose consumption (B) and ethanol production (C) were 
compared. The DCT-1 is represented in the gray circle, and the DCT-2 strain is represented by 





Figure 3.3 Serial subcultures of the DCT-2 strain on cellobiose and fermentation profile of the 
isolated colonies from the last enriched culture. Growth (gray circle with cross) and cellobiose 
consumption (white circle with cross) were measured (A).  As growth rate and cellobiose 
consumption rate saturated at ninth transfer, single colonies were isolated. Cell growth and 
cellobiose consumption of the original DCT-2 and three single isolated colonies from the 
evolved DCT-2 were compared (B). Three single colonies of the evolved DCT-2, and the 







Figure 3.4 Amino acid change due to a point mutation in CDT-2 and relative expression level of 
CDT-2 wildtype and CDT-2 mutant with GFP tagging and intracellular cellobiose. Transporter 
homology model prediction of CDT-2 based on the Phyre2 online program (A). The arrow 
represents the mutation N306I in CDT-2 (left) and nearest glucose binding site (N294) site from 
alignment to E. coli XylE bound to glucose (PDB entry 4GBZ). Glucose is shown in VDW model. 
S. cerevisiae strains expressing only CDT-2-GFP or CDT-2m-GFP were cultured in SCD and 
fluorescence level was measured at stationary phase for relative expression level (B). 
Intracellular cellobiose of strains only expressing CDT-2 or CDT-2m were measured after 





Figure 3.5 Comparison of fermentation profile by S. cerevisiae DBT-2m expressing the CDT-2 
N306I and GH1-1 and S. cerevisiae DCT-2m expressing the CDT-2 N306I and CBP. Cell 
growth (A), cellobiose consumption (B), ethanol production (C) and cellodextrin accumulation 
(D) were compared. The DBT-2m and DCT-2m strains are represented in the gray circle and 





Table 3.1 The list of plasmids and S. cerevisiae strains used in this study 
Plasmids and strains Relevant features Sources and references 
Plasmids 
pRS425PGK LEU2, PPGK -MCS- TCYC,  2μ origin, Ampr    [41] 
pRS426PGK URA3, PPGK -MCS- TCYC,  2μ origin, Ampr    [41] 
pRS425-SdCBP LEU2, PPGK-Sdcbp-TCYC, 2μ origin, Ampr   [45] 
pRS425-gh1-1 LEU2, PPGK-gh1-1-TCYC, 2μ origin, Ampr   [41] 
pRS426-cdt-1 URA3, PPGK-cdt-1-TCYC, 2μ origin, Ampr   [41] 
pRS426-cdt-2 URA3, PPGK-cdt-2-TCYC, 2μ origin, Ampr   [41] 
pRS426-cdt-2-gfp URA3, PPGK-cdt-2-gfp-TCYC, 2μ origin, Ampr   This study 
pRS426-mcdt-2-gfp URA3, PPGK-cdt-2-gfp N306I-TCYC, 2μ origin, Ampr   This study 
Strains 
D452-2 MATα leu2 his3 ura3 can1 [97] 
DCT-1 D452-2/ pRS425-SdCBP/pRS426-cdt-1 This study 
DCT-2 D452-2/ pRS425-SdCBP/pRS426-cdt-2 This study 
DCT-2m D452-2/pRS425-SdCBP/pRS426-cdt2 N306I This study 
DBT-2 D452-2/pRS425-gh1-1/pRS426-cdt2-gfp This study 








YEtOH1 PEtOH1 YEtOH1 PEtOH1 
DCT-1 0.35 ± 0.00 0.26 ± 0.00 0.44 ± 0.00 0.09 ± 0.00 
DCT-2 0.21 ± 0.00 0.07 ± 0.00 0.39 ± 0.00 0.03 ± 0.00 
DCT-2m 0.42 ± 0.01 0.70 ± 0.01 0.45 ± 0.00 0.11 ± 0.00 
DBT-22 0.19 ± 0.00 0.11 ± 0.00 0.28 ± 0.00 0.13 ± 0.00 
DBT-2m 0.33 ± 0.00 0.36 ± 0.00 0.32 ± 0.00 0.21 ± 0.00 
1 Fermentation parameters: YEtOH, ethanol yield (grams of ethanol per gram of sugar); PEtOH, 
ethanol productivity (grams of ethanol per liter per hour) calculated at the end of fermentation 











CHAPTER IV: QTL Mapping Analysis for Enhanced Xylose Utilization in Engineered 
Saccharomyces cerevisiae 3 
 
 4.1 Introduction 
For efficient utilization of lignocellulosic sugars such as xylose, Saccharomyces 
cerevisiae strains should be engineered to express xylose assimilation pathway taken from 
native xylose-fermenting yeast such as Scheffersomyces stipitis. Previous studies successfully 
developed the xylose-fermenting yeasts by expressing xylose reductase (XR, encoded by 
XYL1), xylitol dehydrogenase (XDH, encoded by XYL2) and xylulose kinase (XK, encoded by 
XYL3) [30, 71, 72, 109]. Additionally, few genetic perturbations such as PHO13 deletion allowed 
enhanced xylose fermentation [39, 78]. The efficiency of xylose fermentation remains to be less 
efficient compared to glucose fermentation.  
Both rational and traditional combinatorial metabolic engineering have been employed to 
develop a strain with improved xylose-fermenting properties [77]. Many previous studies 
reported the successful application of both metabolic engineering approaches [78, 79]. 
Methodologies are often optimized for the monogenic effects focusing on a single gene effect on 
the desired phenotype. However, many observed phenotypes are complex (quantitative) traits, 
resulting from interactions of many genes. For example, xylose fermentation in yeast is a 
complex trait. A simple expression of the xylose-assimilating pathway in different yeast host 
strains result in different xylose fermentation pattern owing to the variance of the host strains. 
Current metabolic engineering approaches may be limited for determining complex traits. I 
hypothesized that QTL mapping analysis could be effective for identification of the genes 
responsible for robustness.  
Traditional methodologies for identifying quantitative traits are depended on the two 
major factors: phenotypic (trait) evaluation and genotypic (genetic sequences) evaluation. 
Quantitative Trait Locus (QTL) mapping analysis is a widely accepted analysis used in various 
fields of study such as plant biology, medicine, and microbiology [80]. Many studies in metabolic 
engineering of microbes performed QTL mapping analysis that allowed identification genetic 





targets for strain improvement [81-89]. The analysis allows linking statistically phenotypic and 
genotypic data for determining the genetic basis of the trait of interest. To qualify for QTL 
mapping analysis, two strains within the same species that differ genetically and phenotypically 
are required. The parental strains are then crossed to generate daughter cells that contain 
fractions of the genome from its parental strains. These individual progenies are evaluated for 
the trait of interest, and their genotype (sequence) data is obtained. For the genotypic 
evaluation, the differences such as single nucleotide polymorphisms (SNPs), indels, and 
transposable element locations are used as the marker [122, 123]. The sequences the 
individual progenies are mapped to the parental strains’ genome as a reference and 
segregation pattern of the marker will be analyzed statistically for the association of the traits. 
Ideally, markers (i.e. SNPs) of the genetic sequences linked to the trait of interest will be highly 
segregated whereas unlinked markers will remain unsegregated [124].  
Although QTL mapping analysis is a well-accepted tool for determining the genetic basis 
for a complex trait, there are a few problems with this method. The biggest limitation is the 
sample size of the progeny obtained from crossing parental strains. A sample size of the 
progeny is a critical factor that can determine the effectiveness of the QTL analysis result. A 
small number of the sample may result in failure of predicting the QTL associated with the trait 
[125]. Also, a large number of the sample may be extremely laborious to evaluate the traits and 
costly to sequence all of its genomes [124]. Regarding QTL analysis of the microorganisms, 
promising solutions to a sample size requires using bulk or large pools of segregants [126-131]. 
Instead of isolating each recombinant cell and using as each sample, the pool of recombinant 
individuals will be used for phenotyping and genotyping. Because the pool contains extremely 
varied recombinant individuals, the resulting QTL result will be more significant for predicting the 
correct QTL. Therefore, this study presents an extreme QTL (x-QTL) analysis of xylose 
fermentation in engineered S. cerevisiae to elucidate genetic interaction for enhanced xylose 
fermentation.   
 
4.2 Materials and methods 
Strains and Plasmids 
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All strains and plasmids used in the study are listed in Table 4.1. The mutant allele, 
ura3-52, from D452-2 [97] was introduced into both S288Cm and JAY291m strain for generating 
uracil auxotrophic strain. Strains were selected on SCD agar plates (synthetic complete media; 
6.7 g/L yeast nitrogen base with ammonium sulfate, 0.79 g/L of complete supplement mixture 
with appropriate amino acid dropout (Bio 101, Vista, CA) and 20 g/L glucose) containing 1 g/L 5-
fluoroorotic acid (5-FOA). Next, xylose-fermenting strains were constructed by integrating 
linearized pSR6 X123 plasmid [71] at URA3 locus generating S288C X123 and JAY291 X123. 
The transformant was selected on SCD agar plate without uracil. 
Fermentation experiments  
To prepare yeast strains, yeast cells were cultivated in YPD medium (10 g/L yeast 
extract, 20 g/L peptone, and 20 g/L glucose) at 30°C and 250 rpm. Cells were harvested at late 
exponential phase by centrifugation and washed two times with sterile water. YPX medium (YP 
medium with appropriate concentrations of xylose) was used for main fermentation. All flask-
scale fermentation experiments were performed in 50 mL culture using a 250 mL Erlenmeyer 
flask tightly covered with aluminum foil at 30°C and 100 rpm of rotation speed. Initial cell 
densities of all fermentation experiments were adjusted to OD600 of 1. All flask-scale 
fermentation experiments were performed in duplicates. 
Analytical methods 
Cell growth was monitored by measuring optical density (OD) at 600 nm using a UV-
visible spectrophotometer (Biomate5, Thermo, Rochester, NY). Xylose, xylitol, and ethanol 
concentrations were determined by high-performance liquid chromatography (HPLC, Agilent 
Technologies 1200 Series, Mississauga, CA) equipped with a refractive index detector using a 
Rezex ROA-Organic Acid H+ (8%) column (Phenomenex Inc., Torrance, CA). The column was 
eluted with 0.005 N of H2SO4 at a flow rate of 0.6 ml/min at 50°C. 
Mating and recombinant segregant pool generation 
 Two parental strains, S288C X123 and JAY291 X123, were crossed to generate hybrid 
diploid strain SJ X123. Then SJ X123 strain was grown overnight in YPD 20 g/L at 30°C and 
250 rpm. Cells were harvested (5mL, OD600 ~10), washed with sterile water twice and inoculated 
into 500 mL of sporulation media (10 g/L potassium acetate, 0.1 g/L yeast extract, 0.5 g/L 
glucose). Yeasts were sporulated at ambient temperature (~22°C), periodically monitoring for a 
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fraction of tetrad formation of the population by light microscopy. When ~70-80% of the culture 
was sporulated (~7 days), cells were harvested. Only MATa haploid was obtained by magic 
marker selection system, from the previously described method [127]. Harvested cultures were 
treated with Zymolyase and vortexed with glass beads to digest ascus and release ascospores. 
Then Zymolyase treated culture were diluted 100-fold and plated onto magic medium and 
incubated at 30°C until spores were germinated. Collected strains were suspended in 15% 
glycerol and stored at -80°C. 
Serial subculture to enrich superior xylose-fermenting segregants 
The pool of recombinant segregants obtained from mating two parental strains was 
activated in YPD for ~2 hours at 30°C. Initial cell density equal to an OD600 of 0.25 was 
inoculated in 50 mL of YP medium with 80 g/L of glucose or xylose using 250 mL Erlenmeyer 
flasks. When the sugar concentrations reached below 10 g/L, but not completely depleted, 
inoculum equivalent to an OD600 of 0.25 was collected and transferred to a new 50mL of YP 
medium with 80 g/L sugar.  This step was repeated five times until xylose consumption rate was 
saturated. Initial pool population and enriched populations from each transfer were harvested for 
genomic DNA extraction to prepare for whole genome sequencing. 
Whole genome sequencing of segregant population and QTL identification 
 Whole genome sequencing was performed by the University of Illinois at Urbana-
Champaign Biotechnology Center, High-Throughput Sequencing and Genotyping Unit (Urbana, 
IL) using Illumina HiSeq 2500 platform to produced ~100bp paired ends. The reads were 
mapped to the S288C reference genome. Then the variant detection and filtering were 
performed as described previously [119], and about 46,000 segregating sites are used as a 
marker and mapped to S288C genome and calculated for the allele frequency.  
CRISPR/Cas-based genome editing for strain engineering 
CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-
Associated Proteins) based genome editing system was for all strains engineering. Previously 
established technique in our lab was used [67, 132]. The pRS42N Cas9 plasmid was 
transformed into S. cerevisiae strain first then Cas9 carrying strain was used as host strain for 
further genetic modifications. Plasmid carrying guided RNA for targeting each QTL regions with 
the double stranded repairing donor DNA were transformed into Cas9 carrying strains. All 
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transformation method was adapted from PEG-LiAc high-efficiency yeast transformation method 
[133] and selected on yeast extract-peptone (YP) medium with 20 g/L of glucose and with 
appropriate antibiotic markers. All strains and plasmids used in the study are listed in Table 4.1. 
Growth assay with BioscreenC 
 Yeast strains with a deletion in QTL or swapped allele was grown overnight in 5mL YPD 
medium, harvested, and washed twice with sterile water. Cell density equivalent to OD600 0.01 
was used in 200 μL YPX 40 g/L. The BioscreenC (Growth Curves USA, Piscataway, NJ 08854) 
was used to observe growth by monitoring OD600. All strains were performed in triplicates.  
 
4.3 Results 
Construction of the two platform xylose-fermenting S. cerevisiae strains with a different 
genetic background   
To perform QTL analysis of xylose-fermenting S. cerevisiae, two parental haploid strains 
S288C and JAY291 that are highly variant were selected. To ferment xylose in S. cerevisiae, 
xylose metabolic pathway consisting of XYL1, XYL2, and XYL3 from Scheffersomyces stipitis 
were integrated. The resulting strains (S288C X123 and JAY291 X123) were then tested for 
xylose-fermenting capability. Initially, JAY291 X123 xylose fermentation was superior compared 
to S288C X123 strain. However, S288C X123 readily evolved every fermentation experiment 
performed at my hand. In the end, evolved strain was isolated from the culture. Then evolved 
S288C X123 strain was compared to JAY291 X123 strain (Figure 4.2A). With unknown 
mutation, xylose fermentation of the S288C X123 outperformed JAY291 X123. Overall growth, 
xylose consumption rate, ethanol production rate was enhanced as well as decreased xylitol 
accumulation, an undesirable byproduct of xylose fermentation. From the previous study, 
PHO13 mutation allows rapid xylose fermentation [39]. Thus PHO13 gene was sequenced to 
detect any mutations in the gene. No mutation was detected in PHO13 sequence from the 
S288C X123. Based on the xQTL analysis method, the beneficial mutations will be enriched in 
selected progeny. Therefore, JAY291 X123 and evolved S288C X123 was used as two parental 
strains for xylose xQTL experiments. 
Generation of the recombinant segregants from hybrid S288C X123 and JAY291 X123.  
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To perform xQTL mapping analysis, the first step is to generate a pool of recombinant 
segregants that exhibit shuffled genomes from the two parental strains, S288C X123 and 
JAY291 X123. Two parental strains were crossed to generate a hybrid diploid. Then the diploid 
strain was incubated in sporulation medium to induce sporulation. After successful formation of 
tetrads, the culture was harvested and treated to Zymolyase to remove the ascus surround the 
tetrad. Because the culture contains unsporulated diploids and both MATa and MATalpha 
haploids from tetrads, magic marker selection system was employed. Using mating type-specific 
induction of selective marker and using toxic homologs of amino acids (canavanine and 
thialysin) only one mating type will survive and kill the another mating type as well as diploids 
[134].   
Enrichment of the segregant pool for selection of superior xylose fermenter.   
The pool of haploid strains that have various recombinant genome from its parental strains 
was obtained. Then the pool was cultured in xylose conditions to obtain enriched culture 
consumes xylose at a faster rate. The pool was grown in 80 g/L of xylose to apply a strong 
selective pressure. Primarily, xylose consumption and ethanol production patterns were 
monitored to observe xylose fermentation rate enhancement (Figure 4.2B). When most the 
sugar was consumed during each batch of fermentation, a fraction of the population (the 
equivalent of cell density of OD600 0.25) was inoculated into a fresh medium containing 80 g/L of 
xylose. This step was repeated until the good xylose-fermenting strains were saturated 
indicated by xylose consumption rate saturation (Figure 4.2B and C). A total of five rounds of 
subculturing was performed, and each batch constantly increased xylose consumption rate and 
ethanol productivity (Figure 4.2C). The original population of segregants and the fraction of the 
population at the end of each transfer was saved for further analysis. As a control, the same 
enrichment experiments with the initial batch of segregants were performed under 80 g/L of 
glucose for five transfers. The fraction of each batch from glucose enrichments was saved as 
well. 
Whole genome sequencing of the enriched culture xQTL mapping analysis of the 
genome sequencing result  
To map QTL for xylose fermentation, the genomic DNA from the parental strains (S288C 
X123 and JAY291 X123) and population from each round of fermentation were prepared for 
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whole genome sequencing. Illumina sequencing technology was used for the genome 
sequencing. The results were then used for xQTL mapping analysis. There are ~46,000 SNP 
differences between the two parental strains and used as a molecular marker to for QTL 
analysis. Variants were mapped to the S288C reference genome and calculated for the allele 
frequency as shown in Figure 4.3. Any enriched region during xylose fermentation from S288C 
X123 is indicated by allele frequency higher than 0.5 and lower than 0.5 if the region originates 
from JAY291 X123. About 25 potential QTL was identified among 9 of them showed highly 
significant QTLs (Table 4.2) and did not overlap with other QTL studies[131].  Also, marker 
segregation of mating type locus MAT, CAN1, and LYP1 gene indicates the robustness of the 
selection of haploid strain used for the analysis. 
 Because genome mapping was primarily based on the S288C reference genome, 
sequence comparison to JAY291 was also performed. There are 11 unique genes exist in 
JAY291 but absent in S288C. To observe if any of these 11 genes are enriched, the coverage 
ratio or read-depth estimation was compared between the genome sequence from initial pool 
and xylose enriched pool. As shown in Figure 4.4, the coverage ratio remained ~1.0 for all 11 
unique JAY291 genes.  
Screening of the identified QTLs and allele swapping of the identified QTL region and 
elucidate genetic information of the enhanced xylose fermentation. 
To determine the order of putative significance and to consider the ideal approach of the 
experiment, I utilized the allele frequency peak development with genomic information obtained 
from intermediate population during enrichment and the length of the QTLs (Table 4.1). I 
hypothesized that QTLs with a stronger link to the xylose fermentation would develop more 
rapidly during enrichment. Also, the shorter region will cover fewer genes that allow likelihood of 
finding a specific determinant for enhanced xylose fermentation. The QTL 1, 2 and 3 (Chr 4, Chr 
8 and Chr 11) were tested initially, and all three regions are S288C favorable. The length of 
each region is 27.7 (Chr 4), 22.7 (Chr 8) and 18.3 Kbp (Chr 11) and divided into four sub-
regions (~5-6 Kbp) to swap with another genome (S288C allele to JAY291, first). Deletion of 
each sub-region was also performed to observe any impact on the xylose fermentation. The cell 
density measurement using BioscreenC at 36 hours is presented in Figure 4.5. Deletion of the 
region did not impact growth on xylose except for sub-region 8-4 and 11-4 strain (Figure 4.5A). 
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However, the growth of 8-4 was recovered by swapping with the S288C allele. Also, swapping 
the region with 4-2 and 4-4 was detrimental to growth on xylose.   
 
4.4 Discussion 
S288C strain, a haploid prototrophic laboratory strain, was one of the first strains for 
which the full genome was sequenced. Also, it is widely used as a reference strain. JAY291 is a 
haploid strain derived from yeast isolated from Brazil ethanol plant origin. Its genome was 
recently sequenced and is available for use by researchers to utilize. As distant as the origins of 
the two strains, their genome is also highly variant (~46,000 SNP differences). From this 
information, I hypothesized xylose fermentation capability of the two strains would be different 
and S288C, and JAY291 can be good parental strains for QTL analysis.  Initially, XYL1, XYL2, 
and XYL3, which are the minimal required genes for xylose utilization, was integrated into both 
S288C and JAY291 strains. Next, the resulting strains S288C X123 and JAY291 X123 were 
evaluated for xylose fermentation capability. Initially, S288C X123 was poorer xylose-fermenting 
strain compared to JAY291 X123. However, the strain readily evolved every time grown under 
xylose condition. So, evolved S288C X123 was isolated, and xylose fermentation pattern 
compared to JAY291 X123 (Figure 4.1A). Evolved S288C X123 exhibited better xylose 
fermentation compared to JAY291 X123. Previous studies showed mutation at PHO13, 
discovered by laboratory evolution, drastically improved xylose fermentation [39, 78]. Thus, the 
PHO13 sequence of the evolved S288C X123 was examined, and no differences were 
detected. Because evolved S288C X123 and JAY291 X123 still exhibited different xylose 
fermentation, qualification as parental strains for QTL analysis was still valid.  
To generate recombinant segregants, two parental strain were crossed, and the large 
population was sporulated. The resulting spores were selected on magic medium to obtain only 
one mating type haploids. Then, a fraction of the recombinant spores was enriched under 80 g/L 
of xylose. When xylose was depleted from the media, a fraction of the cells was transferred to 
the fresh xylose medium to saturate the population with superior xylose fermenters (Figure 4.2B 
and C). As a control, a fraction of the initial recombinant spores was ‘enriched’ under glucose.  
The genomic DNA from initial population, as well as population saved at each batch during 
enrichment, was sequenced (both glucose and xylose). Using ~46,000 SNP differences as a 
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molecular marker, the whole genome sequences were mapped to the S288C reference genome 
and calculated for allele frequency (Figure 4.3). The genome sequence of xylose enriched 
strains (red line) shows various unique peaks, indicating that regions were enriched, or 
conserved, during growth under xylose possibly favorable for xylose utilization. The 16 genes 
identified only in JAY291 strains were also examined. Read depth of xylose-enriched population 
was compared to the initial population, and there was not change in the coverage ratio. This 
data indicates none of the JAY291 unique genes are favorable for xylose fermentation.  
Over ~20 possible QTL peaks were identified; however, nine most likely QTL regions 
were selected and listed in Table 4.1. QTL regions exceeding 200 Kbp or overlap with other 
QTL studies (likely to be enriched for QTL process, not xylose fermentation) were excluded. 
Most QTL regions were S288C favorable indicating S288C allele is favorable for xylose 
fermentation. Initially, the three shortest QTLs were examined due to increased likelihood of 
finding responsible genes for xylose fermentation (QTL 1-3, Chr 4, 11 and 8). Following the 
traditional method for QTL analysis, each QTL regions divided into 5-6 Kbp regions and 
swapped with the other allele. Additionally, deleting of the regions were studied (Figure 4.5). 
First, JAY291 X123 was used as a host. The deletion of each 5 Kbp fragments did not impact 
xylose fermentation Except for regions Δ8-4 and Δ11-4 (Figure 4.5A). The growth defect of Δ8-
4 was recovered by swapping the region with S288C allele, indicating deletion in generally 
decreased growth fitness. On the other hand, surprisingly, swapping the region with S288C 
allele had a detrimental effect on strains 4-2 and 4-4. All QTL regions tested were S288C 
favorable, therefore, expressing S288C allele should be beneficial for xylose fermentation. 
Possibly, an S288C allele of 4-2 and 4-4 region brings negative interaction yielding inability to 
grow on xylose. No further QTL regions were performed due to lengthy QTL region and low 
likelihood of finding a xylose utilization enhancer gene. 
This study attempted to overcome major challenges for developing optimal yeast strains 
xylose fermentation. Specifically, this project attempted to identify and understand the genetic 
element for beneficial phenotypes of xylose utilization in S. cerevisiae. Although successful QTL 
analysis was performed, results obtained from this project does not provide sufficient 
information for to elucidate possible factors crucial for xylose fermentation. Broad QTL region 
indicates very complex genetic. However, various genome sequences for xylose-fermenting 
strains were obtained. Perhaps, the different bioinformatic approach can be applied. For 
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example, gene duplication change during enrichment can be investigated. For example, the 
relative copy number of URA3 locus, which was used for X123 cassette integration site, 
increased around 2-3 fold during enrichment. The data can indicate increased copy number of 
the X123 cassette, therefore increased xylose fermentation. Thus, although I did not find 
significant genetic players for xylose fermentation by QTL approach, the further bioinformatic 









Figure 4.1 Schematic diagram for generating recombinant segregants for QTL plot generation. 
Two parental haploid strains, S288C X123 and JAY291 X123, are mated to obtain hybrid 
diploid. After sporulation, a pool recombinant segregants are generated. A sample of resulting 
recombinant segregants are used as a control, and another sample is enriched under a 
selective pressure (xylose). Control and selected pool of segregrant genomic DNA are 





Figure 4.2 Xylose fermentation profile of two parental haploid strains and enrichment of 
resulting recombinant segregants under xylose-fermenting condition. (A) Xylose fermentation of 
S288C X123 and JAY291 X123 under 40 g/L of xylose. Cell growth, xylose consumption, 
ethanol production and xylitol accumulation pattern is shown in the first, second, third and fourth 
column, respectively. (B) Recombinant segregant pool resulting from crossing S288C X123 and 
JAY291 X23 and sporulation were enriched under 80 g/L of xylose for the selection of superior 
xylose-fermenting strain. Cells were harvested before xylose was depleted and transferred to 
fresh medium until xylose fermentation rate improvement was saturated. (C) Xylose 
consumption rate and ethanol productivity over each transfer were compared.  






































































































































Figure 4.3 High-resolution genome mapping of faster xylose-fermenting QTLs. All sequenced 
genome was mapped to S288C as a reference. The light red line indicates the sequence of an 
initial pool of segregants and dark red indicates last xylose-enriched batch. Light blue and dark 
blue indicates an initial and final batch of the glucose enrichment used as a control. The 










Figure 4.4 Coverage ratio of the genes unique to the JAY291 strain. The total to 16 genes’ 
sequences read-depth of initial segregant pool and xylose enriched pool was compared.   
















Figure 4.5 Growth on xylose by JAY291 X123 with selected QTL regions deleted (A) and 
swapped (B). The allele swapping of QTL from Chromosome 11 (swapped allele strains 11-1 -
11-4) was not tested. The OD600 measurements at 36 hours were compared.  
  









































Table 4.1 The list of plasmids and S. cerevisiae strains used in this study 
 
  
Strain/Plasmid Relevant characteristic(s)/Description Source or Reference 
Strains 
S288Cm MATα hoΔ::HphMX4 can1Δ::prSTE2-SpHIS5 lyp1Δ his3Δ1::NatMX4 [131] 
S288Cm-u S288Cm strain with mutant allele of ura3 This study 
S288C X123 S288Cm pSR6-X123 evolved This study 
JAY291m MATa ho his3Δ::KanMX NAT [131] 
JAY291m-u JAY291m strain with mutant allele of ura3 This study 
JAY291 X123 JAY291m pSR6-X123 This study 
SJ X123 Resulting diploid by crossing S288CX123 and JAY291 X123 This study 
D452-2  MATα leu2 his3 ura3 can1 This study 
Plasmids 
pSR6-X123 pRS306 TDHp-XYL1-TDH3t PGK1p-XYL2-PGK1t TDH2p-XYL3-TDH3t [71] 
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QTL # Chromosome Peak position 
Length 
(Kbp) Favorability 
1 XI 233377.9 18.3 S288C 
2 VIII 455723.6 22.7 S288C 
3 IV 1156577 27.7 S288C 
4 XIII 282038.7 47 S288C 
5 XVI 499815.2 47.1 S288C 
6 II 102207.9 91.3 JAY291 
7 XII 87601.8 151.4 JAY291 
8 X 120219.8 166.9 S288C 
9 IX 170002.7 209.7 JAY291 
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CHAPTER V: Enhanced Glucose and Galactose Fermentation by Engineered Yeast 
Harboring TPS1 Deletion and Mutant HXK2 4 
 
5.1 Introduction 
 Saccharomyces cerevisiae is a traditional yeast, highly instrumental to brewing and 
bioethanol industries due to its superior glucose fermenting capability. Also, it is one of the 
intensively studied eukaryotic systems in molecular and cell biology, allowing advantages as a 
host for metabolic engineering of production of fuels and chemicals [135]. Although various 
strains can differ fermentation capability, S. cerevisiae strains prioritize utilization of glucose 
although it is capable of fermenting other sugars, creating glucose repression. During glucose 
repression, yeast inhibits the synthesis of enzymes involved in non-glucose utilization, 
gluconeogenesis, respiration and peroxisomal function and activate glucose fermentation 
related enzymes [136-138]. While glucose repression can be favorable for glucose fermentation 
to produce ethanol, it is a challenging barrier to overcome for non-glucose sugar utilization and 
chemical production by engineered yeast. For example, glucose repression can contribute to 
inefficient utilization of cellulosic sugars, containing both glucose and various other sugars. 
During mixed sugar fermentation, glucose will be used first then other sugars resulting in 
inefficient fermentation process [44, 72]. Thus, controlling and overcoming glucose repression 
should be addressed for efficient fuels and chemical production. 
 Glucose sensing starts with sensing extracellular glucose via Snf3/Rgt2 complex. The 
Snf3/Rgt2 complex act as a receptor for monitoring extracellular glucose concentration. Snf3 
serve as a high-affinity glucose sensor inducing expression high-affinity hexose transporters 
(HXT 2 and 4) and Rgt2 act as a low-affinity glucose sensor inducing expression of low-affinity 
hexose transporter (HXT1 and 3). The Snf3/Rgt2 complex is also involved in the expression of 
genes such as HXK2 and MIG1 related to glucose metabolism repression [139]. The glucose 
signaling transduction also activates cAMP/PKA pathway, that regulates overall cellular 
physiology including growth, metabolism, stress response, etc. [136, 140]. Once glucose is 
transported into the cell, intracellular glucose sensing mechanism activates. Glucose-6-
phosphate, produced by phosphorylating glucose by hexokinases (Hxk1, Hxk2, and Glk1) is 





required for intracellular glucose signaling affecting overall glycolytic flux rate. Snf1 protein 
kinase complex or yeast AMPK complex modifies transcription of various genes under stressful 
conditions (i.e. no available nutrient) (Figure 5.1) [140].  
 As illustrated in Figure 5.1, glucose repression mechanisms involve numerous genes 
related to sensing, signaling transduction, metabolism and stress responses. Although overall 
glucose repression mechanism is demonstrated, actual influence on glucose utilization is not 
well elucidated. Thus, this study investigates glucose fermentation capability of 50 gene targets 
selected based on their role in glucose sensing, signaling transduction, metabolism and stress 
responses. To evaluate the effect of each gene, the yeast deletion library strains were utilized. I 
found ΔTPS1 with suppressor mutation changed glucose utilization pattern and aimed to 
elucidate phenotype changes caused in ΔTPS1 with suppressor mutation strain.  
 
5.2 Materials and methods 
Strains and culture conditions 
S. cerevisiae strains used in this study were summarized in Table 5.1. To create TPS1 
deletion strain, ΔTPS1::KanMX fragment from BY YKO ΔTPS1 amplified and integrated to 
BY4742. Mating and tetrad dissection was used to create hybrid diploid and resulting progenies. 
To create mHXK2 strain, CRISPR/Cas-based genome editing was used. Yeast cells were 
routinely cultured in the Yeast extract-peptone and glucose or galactose (YPD or YPG, 10 g/L 
yeast extract, 20 g/L peptone, and 20 g/L glucose or galactose) medium to prepare initial 
inoculum at 30°C with 250 rpm agitation speed. Synthetic complete (SC, 6.7 g/L yeast nitrogen 
base with ammonium sulfate,0.79 g/L complete supplement mixture (CSM, (Bio 101, Vista, CA)) 
media and appropriate concentrations of glucose and galactose were used in fermentation 
experiments. 
Plasmid construction 
All primers, template plasmids, and constructed plasmids are listed in Table 1 and 2. The 
gene expressing plasmids used in this study are based on pRS series vectors with an antibiotic 
marker (Table 5.1, [141]). The guide RNA(gRNA) targeting HXK2 was synthesized by gBlock 
from IDT Inc. The gBlocks for gRNAs were synthesized with the recognition site of each gene 
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and flanking sequences for SacI and KpnI restriction enzyme digestion. Then the gBlock and 
42H vector plasmids were digested with SacI and KpnI enzyme. Resulting gBlocks and vectors 
were ligated and transformed into E. coli for plasmid amplification.  
CRISPR/Cas-based genome editing for strain engineering 
CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-
Associated Proteins) based genome editing system was for all strains engineering. Previously 
established technique in our lab was used [67, 132]. The pRS42N Cas9 plasmid was 
transformed into S. cerevisiae strain first then Cas9 carrying strain was used as host strain for 
further genetic modifications. Plasmid carrying guided RNA for HXK2 with the double stranded 
repairing donor DNA were transformed into Cas9 carrying strains. All transformation method 
was adapted from PEG-LiAc high-efficiency yeast transformation method [133] and selected on 
yeast extract-peptone (YP) medium with 20 g/L of glucose and with appropriate antibiotic 
markers. All strains and plasmids used in the study are listed in Table 5.1. 
Fermentation experiments 
To prepare yeast strains for fermentation experiments, yeast cells were cultivated in 
YPD medium at 30°C and 250 rpm. Cells were harvested at exponential phase by centrifugation 
and washed twice with sterile water. Flask-scale Fermentation experiments were performed in 
SC media with appropriate concentrations of glucose or galactose. All flask-scale fermentation 
experiments were performed in 50 mL culture using a 250 mL Erlenmeyer flask tightly covered 
with aluminum foil at 30°C and 100 rpm of rotation speed. Initial cell densities of all fermentation 
experiments were adjusted to OD600 of 1. All flask-scale fermentation experiments were 
performed in duplicates.  
Analytical methods 
Cell growth was monitored by measuring optical density (OD) at 600 nm using a UV-
visible spectrophotometer (Biomate5, Thermo, Rochester, NY). Glucose, galactose, glycerol, 
and ethanol concentrations were determined by high-performance liquid chromatography 
(HPLC, Agilent Technologies 1200 Series, Mississauga, CA) equipped with a refractive index 
detector using a Rezex ROA-Organic Acid H+ (8%) column (Phenomenex Inc., Torrance, CA). 




 Yeast strains were prepared by growth in 5mL of YPEthanol 20 g/L for two days, 
harvested, and washed twice with sterile water. Ten-fold serial dilution was made with water, 
and five μL of 100, 10-1, 10-2, 10-3, 10-4 and 10-5 were spotted on YPD (glucose) or YPG 
(Galactose), and plates were incubated at 30°C for 2 days.  
Mating and tetrad dissection experiment 
 BY YKO ΔTPS1 and BY4741 were crossed to generate BY diploid. Then BY diploid 
strain was grown overnight in 5 mL of YPD 20 g/L at 30°C and 250 rpm. Cells were harvested 
(OD600 ~10), washed with sterile water twice and inoculated into 25 mL of sporulation media (10 
g/L potassium acetate, 0.1 g/L yeast extract, 0.5 g/L glucose). Yeasts were sporulated for ~five 
days at ambient temperature (~22°C), periodically monitoring for a fraction of tetrad formation 
by light microscopy. Then approximately 1 x 107 cells (~ 20 to 40% tetrad formation) were 
harvested and resuspended in 100 μL of sterile water and treated with two units of Zymolyase 
(E1006, Zymo Research) for 5 min to digest surrounding ascus. Then, another 100 μL cold 
water was added to stop the zymolyase reaction and kept in ice. Five μL of the tetrad containing 
solution was gently streaked on the center of YPD agar plate, and four ascospores were 
separated and placed apart from different cells using micromanipulator. After 2-3 day of 
incubation at 30°C, separated ascospores were obtained and confirmed by mating type locus 
PCR. 
Whole genome sequencing and read mapping 
 The genomic DNA of BY YKO ΔTPS1 and tetrad 1d (ΔTPS1::KanMX, mHXK2) were 
extracted to whole genome sequencing. Whole genome sequencing was performed by the 
University of Illinois at Urbana-Champaign Biotechnology Center, High-Throughput Sequencing 
and Genotyping Unit (Urbana, IL) using Illumina HiSeq 2500 platform. The reads were mapped 
to the S288C reference genome as described previously. CLC Genomic Workbench 7 was used 
to compare genome sequences of the BY YKO ΔTPS1 and tetrad 1c.  
 
5.3 Results 
Glucose fermentation pattern comparison of 50 yeast knockout library 
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 Initially, I selected 50 gene targets related to glucose sensing, signaling, metabolism and 
major stress response to starvation based on past research studies and its significance to 
glucose metabolism can be inferred (Figure 5.1 and Table 5.2). To screen for potential effects 
on the cellular metabolism of the 50 selected gene targets, I obtained BY4742 deletion library 
strains, derivative of S288C strains, that harbor each gene deleted by replacing KanMX 
cassette (BY YKO strains). To observed the deletion effect of each gene, glucose consumption 
pattern was compared first. To amplify the difference of glucose fermentation capability, minimal 
media (SC) with a high concentration of glucose (100 g/L) was used. The lethality of a gene 
knockout was not considered initially with an assumption that it will be indicated with poor or no 
glucose consumption. As shown in Figure 5.2A, total consumed glucose was compared to the 
control (BY4742 wildtype) and percent change was calculated. All 50 strains exhibited various 
patterns of glucose consumption. However, few genes had a significant difference from the 
control. For example, BY YKO ΔTPS1 strain, as noted in figure 5.2A, had the highest positive 
percent change indicating more glucose consumption compared to the wildtype. To examine 
further, glucose fermentation pattern of BY YKO ΔTPS1 was compared to the wildtype. Figure 
5.2B first column shows that ΔTPS1 strain completely consumed 100 g/L of glucose at a slightly 
faster rate and accumulated glycerol significantly (~ 13 g/L (ΔTPS1) vs. ~3 g/L (Wildtype)). 
However, TPS1 deletion is reported to be a lethal under glucose condition [142, 143]. As I 
observed conflicting phenomena of what was already reported, in fact, enhanced glucose 
fermentation, I hypothesized the presence of suppressor mutation to overcome lethality of 
ΔTPS1.  
Utilization of glucose and galactose by various ΔTPS1 mutants 
 To confirm and evaluate ΔTPS1 phenotype without the possibility of suppressor 
mutation, new ΔTPS1 strain (BY4742 ΔTPS1) was constructed by integration of KanMX 
cassette with TPS1 upstream and downstream homology region. Then, growth tests on glucose 
and galactose, under both solid and liquid media conditions (Figure 5.4A and B) were performed 
with BY4742, BY4742 ΔTPS1 and BY YKO ΔTPS1 with potential suppressor mutation(s). 
According to previous studies, strains harboring ΔTPS1 cannot grow under glucose condition 
due to flux imbalance of upper and lower glycolysis [142, 143]. As expected, BY4742 grew on 
both galactose and glucose, and ΔTPS1 only strain (clean mutant) grew under galactose but 
not glucose. Also, agreeing with earlier observation (Figure 5.2), BY YKO ΔTPS1 with potential 
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suppressor mutation(s) grew under both galactose and glucose (Figure 5.4A and B). In general, 
BY YKO ΔTPS1 with potential suppressor mutation had better sugar consumption under both 
glucose and galactose conditions.  
Tetrad dissection and genome sequencing reveals one mutation is responsible for 
rescuing TPS1 lethality 
 After confirmation of ΔTPS1 lethality under glucose and presence of unknown potential 
suppressor mutation(s) in BY YKO ΔTPS1 strain, mating, and tetrad dissection were performed 
to find out how many mutations (genes) are potentially involved suppression of lethality. BY 
YKO ΔTPS1 (MATα) as mated with another S288C-derived strain BY4741 (MATa). Then, 
resulting in hybrid diploid (BY diploid), cells were incubated under sporulation medium to induce 
tetrad formation. After tetrad had been obtained, each set of four haploid progenies were 
obtained by a micromanipulator. A total of 5 sets of tetrads was tested for the presence of 
ΔTPS1:: KanMX cassette under glycerol + G418 media, and growth under glucose and 
galactose. A representative tetrad set, 1a -1d, are shown in Figure 5.4C. Two haploids 1b and 
1c were able to grow under glycerol + G418 condition indicating 1b and 1b harbors ΔTPS1:: 
KanMX. However, only 1c strain colonized under glucose agreeing with the phenotype of BY 
YKO ΔTPS1 with potential suppressor mutation. Five tetrad sets showed similar phenotype 
(data not shown). Thus, the likelihood of observing the phenotype of BY YKO ΔTPS1 with 
potential suppressor mutation is 1/4. By the general equation of phenotype of interest observed 
= one/ 2n, where n is a number of factors (genes) involved, the n equals 2. The TPS1 deletion 
accounts for one, therefore, one other mutation is likely to be involved in rescuing TPS1 deletion 
lethality. 
 To find which gene is involved for allowing growth under glucose with ΔTPS1, whole 
genome sequencing was performed. The genomes of BY YKO ΔTPS1 and tetrad 1c were 
sequenced, and the reads were mapped to the S288C reference genome. The sequence 
alignment indicated a presence of single nucleotide change in HXK2, encoding for hexokinase 2 
in yeast. To confirm, BY YKO ΔTPS1 and tetrad 1a-1d HXK2 gene was sequenced again, and 
BY YKO ΔTPS1, tetrad 1c and 1d had SNP changing amino acid sequence from Ser158 to 
Tyr158. 
Enhanced glucose and galactose fermentation by ΔTPS1 and mHXK2 double mutant 
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 Next, mHXK2 (Ser158Tyr) was introduced in wildtype BY4742, and BY4742 ΔTPS1 to 
observe the effect of mHXK2 during glucose and galactose fermentation. As observed in Figure 
5.5A, the introduction of mHXK2 to ΔTPS1 strain rescued the growth under glucose condition. 
Moreover, strains expressing mHXK2 (BY mHXK2 and BY ΔTPS1 mHXK2) grew better and 
fermented glucose at a faster rate compared to the wildtype BY4742. Galactose fermentation 
was also performed (Figure 5.5B). Under Galactose condition, all strains BY4742, BY ΔTPS1, 
BY mHXK2 and BY ΔTPS1 mHXK2 grew similarly (similar biomass accumulation). However, 
strains with ΔTPS (BY ΔTPS1 and BY ΔTPS1 mHXK2) had better galactose consumption 
followed by strain BY mHXK2 and wildtype. Additionally, at 12 hours, all engineered strain, 
except for BY4742 strain started to grow indicating mHXK2 or ΔTPS1 generally enhances 
galactose fermentation.  
 Expressing mHXK2 or both ΔTPS1 mHXK2 also enhanced mixed sugar utilization of 
glucose and galactose. Under glucose and galactose mixture, BY4742 consumed glucose 
rapidly but were not able to consume galactose after (Figure 5.6 first column). On the other 
hand, strains expressing both mHXK2 or ΔTPS1 mHXK2 consumed glucose rapidly and even 
started to consume galactose before glucose was depleted. Due to poor growth on glucose, the 
ΔTPS1 strain was excluded for mixed sugar fermentation experiments. 
  
5.4 Discussion 
 The glucose sensing mechanism and metabolic network in yeast prioritize glucose 
utilization over any other sugars, creating glucose repression. Understanding the complex 
mechanism of glucose repression is proved to be difficult and can impose a challenging problem 
for metabolic engineering for production of fuels and chemicals. Thus, I attempted to screen 50 
gene targets that might affect glucose fermentation. Targeted genes were selected based on 
previous literature and its function on glucose sensing, signaling, metabolism and major stress 
response to starvation (Table 5.2). To efficiently screen 50 gene targets, yeast deletion library 
was utilized [144]. By studying phenotype change by deletion, I might be able to elucidate 
mechanisms that affect glucose utilization directly. To my knowledge, no previous study reports 
glucose fermentation pattern comparison of many genes concurrently.  
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 As expected, the 50 strains exhibited various glucose consumption pattern (Figure 
5.2A). Some deletions lowered glucose consumption whereas some deletions enhanced 
glucose consumption. Particularly, ΔTPS1 strain (BY YKO ΔTPS1) showed the best 
improvement in glucose consumption. When detailed glucose fermentation pattern of BY YKO 
ΔTPS1 were examined, glucose consumption rate of BY YKO ΔTPS1 was faster than BY4742 
and significant glycerol production was observed (Figure 5.2B). Unexpectedly, however, the 
deletion of TPS1 gene is known to be lethal to the yeast due to its crucial role in glycolysis 
regulation [145, 146]. TPS1 encodes for trehalose phosphate synthase, an enzyme converting 
glucose-6-phosphate to trehalose-6-phosphate. Trehalose-6-phosphate can further be 
converted to trehalose. However, trehalose-6-phophate also act as a regulatory molecule to 
control glycolysis. Energy consuming upper glycolysis is very rapid (glucose to fructose-1,6-
bisphosphate) compared to the energy-generating lower glycolytic pathway (glyceraldehyde-3-
phosphate to pyruvate). When upper and lower glycolytic pathways are not balanced, energy 
imbalance (shortage of ATP) can occur leading to lethality. Trehalose-6-phoshate prevents this 
by controlling the reaction rate of glucose to glucose-6-phosphate. Thus, deletion of TPS1 is 
lethal to the cell. However, BY YKO ΔTPS1 presented normal glycolytic pathway, if not faster 
(Figure 5.2). Therefore, I hypothesized presence of suppressor mutation in BY YKO ΔTPS1 
strain. 
 The phenotype of BY YKO ΔTPS1 reveals that the potential suppressor mutation not 
only removes ΔTPS1 but increase glucose utilization, or increase glycolytic flux (Figure 5.2B 
and Figure 5.4B). To confirm if unknown suppressor mutation increases glycolytic flux, growth 
under galactose was tested. Galactose utilization bypasses hexokinase step but metabolized 
via glycolysis from glucose-6-phosphate (Figure 5.3). If unknown suppressor mutation increases 
overall glycolytic flux, galactose utilization should also increase. As expected, galactose 
fermentation with BY YKO ΔTPS1 increased compared to wildtype yeast indicating the 
unknown mutation increases overall glycolytic rate. However, ΔTPS1 alone (BY4742 ΔTPS1) 
can also increase galactose fermentation slightly.  
 By whole genome sequencing, a mutation at HXK2 (Ser158Tyr), a gene encoding for 
hexokinase two was identified. However, the interaction between TPS1 and HXK2 is already 
known, and my observation agrees with the previous study. The introduction of mHXK2 to newly 
constructed ΔTPS1 strain rescued the ΔTPS1 lethality (Figure 5.5A). Interestingly, the 
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introduction of mHXK2 to both wildtype and ΔTPS1 strain increased the biomass accumulation 
and enhanced glucose fermentation rate. The mutation site of HXK2, Ser158, is known for 
phosphorylating site and reported mutation lowers overall enzyme activity. Thus, the 
introduction of mHXK2 lowers overall efficiency of conversion of glucose to glucose-6-
phosphate and may not cause an imbalance between upper and lower glycolytic pathway. 
Consequently, ΔTPS1 is not lethal anymore when mHXK2 is expressed. Also, nonlethal ΔTPS1 
mutant (with mHXK2) removes the regulation of hexokinase catalytic activity (by HXK1 and 
GLK1). As a result, enhanced glucose fermentation is observed (Figure 5.5A). Galactose 
fermentation was also tested as previous observation (Figure 5.4B) indicated the mutation could 
increase overall glycolytic rate. Generally, mHXK2 can mediate increased galactose utilization 
(indicated by mHXK2 and mHXK2 ΔTPS1 strain), ΔTPS1 was more effective in increasing 
galactose fermentation (indicated by ΔTPS1 and mHXK2 ΔTPS1 strain) (Figure 5.5B). 
The previous studies also reported that mutation at Ser158 also affects glucose 
signaling [147, 148]. Because galactose metabolic enzymes are strictly repressed by glucose 
repression, the introduction of mHXK2 might remove the repression. Thus, mixed sugar 
(glucose and galactose) utilization was tested with the wildtype and mHXK2 expressing strains 
(Figure 5.6). The wildtype strain (BY4742) consumed glucose rapidly. However, galactose was 
barely consumed. On the other hand, mHXK2 expressing strains consumed glucose rapidly and 
started to consume galactose even before glucose was deleted. This result proves the mHXK2 
expression is beneficial to remove repression of galactose metabolism during the presence of 
glucose. 
In summary, BY YKO ΔTPS1 showed a significant change in glucose consumption from 
initial screening. Although combined effect with mHXK2, a change in glucose metabolism was 
observed and provided insights for glucose metabolism network. Additionally, ΔTPS1 and 
mHXK2 are beneficial for enhancing glucose or galactose fermentation. Especially, mHXK2 
removes glucose repression enabling glucose and galactose mixed sugar fermentation that can 
be advantages for utilizing milk sugar lactose (dimer of glucose and galactose). Although this 
study presents clear phenotype change due to genetic perturbation and followed by reasoning, 
the detailed mechanistic investigation was not performed. In the future, detailed investigation of 
Tps1 and mHxk2p interaction should be performed. Additionally, other deletion strains with a 
significant change in glucose consumption should be investigated.  
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Figure 5.1 Schematic diagram of glucose metabolism and signaling transduction pathways 
[136]. PKA (cAMP-dependent protein kinase) transduction pathway, glucose sensing 
transduction pathway, glycolysis, and AMPK (AMP-activated protein kinase) transduction 
pathway is shown. Genes studied in this chapter is shown in black and did not study in gray. 
The blue line indicates a reaction and red line indicates inhibition. Orange circle with a letter ‘p’ 






















































































































Figure 5.2 Fermentation capability of selected YKO strains. Total consumed glucose change 
(A) compared to wildtype (BY4742) is shown. (A) Total consumed glucose was calculated upon 
glucose depletion or ceased glucose consumption from SCD 100 g/L fermentation. Then 
percent change compares to BY4742 was calculated. Positive percent change indicates a 
higher amount of glucose consumption and negative percent change indicates a lower amount 
of glucose consumption compared to BY4742. Error range was determined by control strain 
BY4742 indicated by a gray area. (B) Glucose consumption and glycerol production pattern of 

























































































































































































































































































Figure 5.3 Schematic diagram of glucose and galactose metabolic pathway and role of TPS1. 
Galactose is converted to galactose-1-p by galactokinase (GAL1). Then galactose-1-phosphate 
uridyl transferase (GAL7) synthesizes galactose-1-p and UDP-D-glucose to glucose-1-
phosphate and UDP-galactose. Glucose-1-p is converted to glucose-6-p by 
phosphoglucomutase (PGM 1, 2) and further metabolized by glycolysis. Glucose-6-p and UDP-
D-glucose can be converted to trehalose-6-p by trehalose phosphate synthase (TPS1) and 
regulation by TSL1. Then trehalose-6-p can regulate the glycolytic reactions by controlling 






Figure 5.4 Growth on glucose and galactose by various mutants. (A-B) Growth YPD and YPG 
by spot assay or liquid media were compared between BY4742 (wildtype), BY4742 ΔTPS1 and 
BY YKO ΔTPS1. (A) Colony formation after ~2 days of incubation was observed and (B) Sugar 
consumption pattern under liquid media was observed. (C) Growth test of haploid progenies 
from sporulation of hybrid BY diploid (BY YKO ΔTPS1 x BY4741) and tetrad dissection on 
glycerol + G418, glucose, and galactose medium. The glycerol + G418 plate was used to 
indicate ΔTPS1::KanMX.  
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Figure 5.5 Glucose and galactose fermentation profiles of TPS1 and mHXK2 mutants. (A) 
Growth in glucose, glucose consumption and ethanol production patterns (first, second and third 
column, respectively) of BY4742, ΔTPS1, mHXK2 and ΔTPS1 mHXK2 strains are compared 
and (B) growth on galactose, galactose consumption and ethanol productions are compared 
(first, second and third column, respectively) of BY4742, ΔTPS1, mHXK2 and ΔTPS1 mHXK2 
strains. 
  



















































































































Figure 5.6 Glucose and galactose mixed sugar utilization pattern by BY4742, ΔTPS1, mHXK2 
and ΔTPS1 mHXK2 harboring strains (first, second and third column, respectively). A total of 80 
g/L (40 g/L of glucose and 40 g/L galactose) sugar was used, and concentrations of each sugar 
were monitored. 
  


























































































Table 5.1 The list of plasmids and S. cerevisiae strains used in this study  
  
Strain/Plasmid Relevant characteristic(s)/Description Source or Reference 
Strains 
BY4742 MATα leu2 his3 lys2 ura3 [149] 
BY4741 MATa leu2 his3 met15 ura3 [149] 
BY YKO ΔTPS1 BY4742 ΔTPS1::KanMX from deletion library [144] 
BY diploid Hybrid diploid of BY4741 and BY YKO ΔTPS1 This study 
Tetrad 1a Tetrad from BY diploid This study 
Tetrad 1b Tetrad from BY diploid, ΔTPS1::KanMX This study 
Tetrad 1c Tetrad from BY diploid, ΔTPS1::KanMX. mHXK2 This study 
Tetrad 1d Tetrad from BY diploid, mHXK2 This study 
BY ΔTPS1 BY4742 ΔTPS1::KanMX  This study 
BY mHXK2 BY4742 mHXK2 This study 
BY ΔTPS1 mHXK2 BY4742 ΔTPS1::KanMX  mHXK2 This study 
Plasmids 
pRS42N NAT1 marker plasmid EUROSCARF 
pRS42H HyB marker plasmid EUROSCARF 
pRS42N Cas9 PPGK -MCS- TCYC, Cas9 expression plasmid [67] 
pRS42K gRNA 
HXK2 HXK2 gRNA plasmid This study 
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Table 5.2 List of gene targets and a brief description. 
Gene Brief description (Information from yeastgenome.org) 
ΔGAL80 Transcriptional regulator involved in the repression of GAL genes in the absence of galactose; inhibits transcriptional activation by Gal4p; inhibition relieved by Gal3p or Gal1p binding 
ΔSIP3 
Transcription cofactor; acts through interaction with DNA-bound Snf1p; C-terminal region has a 
putative leucine zipper motif; potential Cdc28p substrate; SIP3 has a paralog, YSP1, that arose from 
the whole genome duplication 
ΔTPK2 
cAMP-dependent protein kinase catalytic subunit; promotes vegetative growth in response to 
nutrients via the Ras-cAMP signaling pathway; partially redundant with Tpk1p and Tpk3p; localizes to 
P-bodes during stationary phase; relocalizes to the cytosol in response to hypoxia 
ΔSIP1 
Alternate beta-unit of the Snf1p kinase complex; may confer substrate specificity; vacuolar protein 
containing KIS (Kinase-Interacting Sequence) and ASC (Association with Snf1 kinase Complex) 
domains involved in protein interactions 
ΔMIG3 
Transcriptional regulator; partially nonfunctional in S288C strains but has a major role in catabolite 
repression and ethanol response in some other strains; involved in response to toxin agents; 
phosphorylation by Snf1p or the Mec1p pathway inactivates Mig3p, allowing induction of damage 
response genes 
ΔGPA2 
Nucleotide binding alpha subunit of the heterotrimeric G protein that interacts with the receptor Gpr1p 
has signaling role in response to nutrients; green fluorescent protein-fusion protein localizes to the 
cell periphery 
ΔGLK1 
Catalyzes the phosphorylation of glucose at C6 in the first irreversible step of glucose metabolism; 
one of three glucose phosphorylating enzymes; expression regulated by non-fermentable carbon 
sources 
ΔRGT1 Glucose-responsive transcription factor; regulates expression of several glucose transporter genes in response to glucose; binds to promoters and acts both as a transcriptional activator and repressor 
ΔTPK3 
cAMP-dependent protein kinase catalytic subunit; promotes vegetative growth in response to 
nutrients via the Ras-cAMP signaling pathway; partially redundant with Tpk1p and Tpk2p; localizes to 
P-bodies during stationary phase 
ΔRAS1 
GTPase involved in G-protein signaling in adenylate cyclase activation; plays a role in cell 
proliferation; localized to the plasma membrane; relative distribution to the nucleus increases upon 
DNA replication stress 
ΔTPK1 
cAMP-dependent protein kinase catalytic subunit; promotes vegetative growth in response to 
nutrients via the Ras-cAMP signaling pathway; inhibited by regulatory subunit Bcy1p in the absence 
of cAMP; regulates Whi3p; partially redundant with Tpk2p and Tpk3p; phosphorylates pre-Tom40p, 
which impairs its import into mitochondria under non-respiratory conditions 
ΔHXK2 
Hexokinase isoenzyme 2; catalyzes phosphorylation of glucose in the cytosol; predominant 
hexokinase during growth on glucose; functions in the nucleus to repress expression of HXK1 and 
GLK1 and to induce expression of its own gene; phosphorylation/ dephosphorylation at serine-14 by 
protein kinase Snf1 and protein phosphatase Glc7p-Reg1p regulates nucleocytoplasmic shuttling of 
Hxk2p  
ΔSIP2 
One of three beta subunits of the Snf1 kinase complex; involved in response to glucose starvation; 





Table 5.2. List of gene targets and a brief description continued. 
Gene Brief description (Information from yeastgenome.org) 
ΔMIG2 
Zinc finger transcriptional repressor; cooperates with Mig1p in glucose-induced repression of many 
genes; under low glucose conditions Mig2p re-localizes to mitochondrion, where it interacts with 
Ups1p and antagonizes mitochondrial fission factor, Dnm1p, indicative of a role in mitochondrial 
fusion or regulation morphology; regulates filamentous growth along with Mig2p in response to 
glucose depletion 
ΔHXK1 
Hexokinase isoenzyme 1; a cytosolic protein that catalyzes phosphorylation of glucose during 
glucose metabolism; expression is highest during growth on non-glucose carbon sources; glucose-
induced repression involves hexokinase Hxk2p 
ΔMIG1 
Transcription factor involved in glucose repression; sequence specific DNA binding protein 
containing two Cys2His2 zinc finger motifs; regulated by the SNF1 kinase and the GLC7 
phosphatase; regulates filamentous growth along with Mig2p in response to glucose depletion 
ΔMTH1 
Negative regulator of the glucose-sensing signal transduction pathway; required for repression of 
transcription by Rgt1p; interacts with Rgt1p and theSnf3p and Rgt2p glucose sensors; 
phosphorylated by Yck1p, triggering Mth1p degradation 
ΔSIP4 
C6 zinc cluster transcriptional activator that binds to the carbon source-responsive element (CSRE) 
of gluconeogenic genes; involved in the positive regulation of gluconeogenesis; regulated by Snf1p 
protein kinase; localized to the nucleus 
ΔGAP1 General amino acid permease; Gap1p senses the presence of amino acid substrates to regulate localization to the plasma membrane when needed; essential for invasive growth 
ΔREG1 Regulatory subunit of type 1 protein phosphatase Glc7p; involved in negative regulation of glucose-repressible genes; involved in regulation of the nucleocytoplasmic shuttling of Hxk2p 
ΔRGT2 Plasma membrane high glucose sensor that regulates glucose transport; contains 12 predicted transmembrane segments and a long C-terminal tail required for induction of hexose transporters 
ΔGRR1 
F-box protein component of an SCF ubiquitin-ligase complex; modular substrate specificity factor 
which associates with core SCF (Cdc53p, Skp1p and Hrt1p/Rbx1p) to form the SCF (Grr1) Complex; 
SCF (Grr1) acts as a ubiquitin-protein ligase directing ubiquitination of substrates such as: Glc2p, 
Mks1p, Mth1p, Cln1p, Cln2p and Cln3p; involved in carbon catabolite repression, glucose-dependent 
divalent cation transport, glucose transport, morphogenesis, and sulfite detoxification 
ΔREG2 
Regulatory subunit of the Glc7p type-1 protein phosphatase; involved with Reg1p, Glc7p, and Snf1 in 
regulation of glucose-repressible genes, also involved in glucose-induced proteolysis of maltose 
permease 
ΔRAS2 GTP-binding protein; regulates nitrogen starvation response, sporulation, and filamentous growth; farnesylation and palmitoylation required for activity and localization to plasma membrane 
ΔSNF3 
Plasma membrane low glucose sensor regulates glucose transport; contains 12 predicted 
transmembrane segments and a long C-terminal tail required for induction of hexose transporters; 
also, senses fructose and mannose 
ΔCYC8 
General transcriptional co-repressor; acts together with Tup1p; also acts as part of a transcriptional 
co-activator complex that recruits the SWI/SNF and SAGA complexes to promoters; can form the 
prion [OCT+] 
ΔGAL83 
One of three possible beta-subunits of the Snf1 kinase complex; allows nuclear localization of the Snf1 
kinase complex in the presence of a nonfermentable carbon source; necessary and sufficient for 




Table 5.2. List of gene targets and a brief description continued. 
Gene Brief description (Information from yeastgenome.org) 
ΔTUP1 
General repressor of transcription; forms complex with Cyc8p, involved in the establishment of 
repressive chromatin structure through interactions with histones H3 and H4, appears to enhance 
expression of some genes  
ΔGPR1 
Plasma membrane G-protein coupled receptor (GPCR); interacts with the heterotrimeric G protein 
alpha subunit, Gpa2p, and with Plc1p; sensor that integrates nutritional signals with the modulation of 
cell fate via PKA and cAMP synthesis 
ΔSNF4 
Activating gamma subunit of the AMP-activated Snf1p kinase complex; additional subunits of the 
complex are Snf1p and a Sip1p/Sip2p/Gal83p family member; activates glucose-repressed genes, 
represses glucose-induced genes; role in sporulation, and peroxisome biogenesis; protein 
abundance increases in response to DNA replication stress 
ΔSNF1 
AMP-activated S/T protein kinase; forms a complex with Snf4p and members of the 
Sip1p/Sip2p/Gal83p family; required for transcription of glucose-repressed genes, thermotolerance, 
sporulation, and peroxisome biogenesis; regulates nucleocytoplasmic shuttling of Hxk2p; regulates 
filamentous growth and acts as a non-canonical GEF, activating Arf3p during invasive growth; 
SUMOylation by Mms21p inhibits its function and targets Snf1p for destruction via the Slx5-Slx8 Ub 
ligase 
ΔTPS1 
Synthase subunit of trehalose-6-P synthase/phosphatase complex; synthesizes the storage 
carbohydrate trehalose. Also found in a monomeric form; expression is induced by the stress 
response and repressed by the Ras-cAMP pathway; protein abundance increases in response to 
DNA replication stress and response to prolonged exposure to boric acid  
ΔTPS2 
Phosphatase subunit of the trehalose-6-P synthase/phosphatase complex; involved in synthesis of 
the storage carbohydrate trehalose; expression is induced by stress conditions and repressed by the 
Ras-cAMP pathway; protein abundance increases in response to DNA replication stress 
ΔZWF1 
Glucose-6-phosphate dehydrogenase (G6PD); catalyzes the first step of the pentose phosphate 
pathway; involved in adapting to oxidative stress; protein abundance increases in response to DNA 
replication stress 
ΔSSK1 
Cytoplasmic phosphorelay intermediate osmosensor and regulator; part of a two-component signal 
transducer that mediates osmosensing via a phosphorelay mechanism; required for mitophagy; 
dephosphorylated form is degraded by the ubiquitin-proteasome system; potential Cdc28p substrate 
ΔREE1 
Cytoplasmic protein involved in the regulation of enolase (ENO1); mRNA expression is induced by 
calcium shortage, copper deficiency (via Mac1p) and the presence of galactose (via Gal4p); mRNA 
expression is also regulated by the cell cycle  
ΔGLC8 
Regulatory subunit of protein phosphatase 1 (Glc7p); involved in glycogen metabolism and 
chromosome segregation; proposed to regulate Glc7p activity via conformational alteration; protein 
abundance increases in response to DNA replication stress  
ΔGAL3 
Transcriptional regulator; involved in activation of the GAL genes in response to galactose; forms a 
complex with Gal80p to relieve Gal80p inhibition of Gal4p; binds galactose and ATP but does not 
have galactokinase activity 
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Table 5.2. List of gene targets and a brief description continued. 
Gene Brief description (Information from yeastgenome.org) 
ΔGCR1 Transcriptional activator of genes involved in glycolysis; DNA-binding protein that interacts and functions with the transcriptional activator Gcr2p 
ΔGCR2 Transcriptional activator of genes involved in glycolysis; interacts and functions with the DNA-binding protein Gcr1p 
ΔTSL1 
Large subunit of trehalose 6-phosphate synthase/phosphatase complex; Tps1p-Tps2p complex 
converts uridine-5'-diphosphoglucose and glucose 6-phosphate to trehalose; contributes to survival 
to acute lethal heat stress; mutant has aneuploidy tolerance; protein abundance increases in 
response to DNA replication stress 
ΔRAM1 Beta subunit of the CAAX farnesyltransferase (FTase); this complex prenylates the a-factor mating pheromone and Ras proteins; required for the membrane localization of Ras proteins and a-factor 
ΔASC1 
G-protein beta subunit and guanine dissociation inhibitor for Gpa2p; ortholog of RACK1 that inhibits 
translation; core component of the small (40S) ribosomal subunit; required to prevent frameshifting at 
ribosomes stalled at repeated CGA codons; regulates P-body formation induced by replication 
stress; represses Gcn4p in the absence of amino acid starvation 
ΔTOR1 
PIK-related protein kinase and rapamycin target; subunit of TORC1, a complex that controls growth 
in response to nutrients by regulating translation, transcription, ribosome biogenesis, nutrient 
transport, and autophagy; involved in meiosis 
ΔPFK27 
6-phosphofructo-2-kinase; catalyzes synthesis of fructose-2,6-bisphosphate; inhibited by 
phosphoenolpyruvate and sn-glycerol 3-phosphate, expression induced by glucose and sucrose, 
transcriptional regulation involves protein kinase A 
ΔYCK1 
Palmitoylated plasma membrane-bound casein kinase I (CK1) isoform; shares redundant functions 
with Yck2p in morphogenesis, proper septin assembly, endocytic trafficking, and glucose sensing; 
stabilized by Sod1p binding in the presence of glucose and oxygen, causing glucose repression of 
respiratory metabolism; involved in the phosphorylation and regulation of glucose sensor Rgt2p 
ΔADR1 
Carbon source-responsive zinc-finger transcription factor; required for transcription of the glucose-
repressed gene ADH2, of peroxisomal protein genes, and of genes required for ethanol, glycerol, 
and fatty acid utilization 
ΔYCK2 
Palmitoylated plasma membrane-bound casein kinase I (CK1) isoform; shares redundant functions 
with Yck1p in morphogenesis, proper septin assembly, endocytic trafficking, and glucose sensing; 
stabilized by Sod1p binding in the presence of glucose and oxygen, causing glucose repression of 
respiratory metabolism; involved in the phosphorylation and regulation of glucose sensor Rgt2p 
ΔGPH1 
Glycogen phosphorylase required for the mobilization of glycogen; non-essential; regulated by cyclic 
AMP-mediated phosphorylation; phosphorylation by Cdc28p may coordinately regulate carbohydrate 
metabolism and the cell cycle; expression is regulated by stress-response elements and by the HOG 
MAP kinase pathway 
ΔYAK1 
Serine-threonine protein kinase; component of a glucose-sensing system that inhibits growth in 
response to glucose availability; upon nutrient deprivation Yak1p phosphorylates Pop2p to regulate 
mRNA deadenylation, the co-repressor Crf1p to inhibit transcription of ribosomal genes, and the 
stress-responsive transcription factors Hsf1p and Msn2p; nuclear localization negatively regulated by 








 Polymer industries account for the third largest manufacturing industry in the US and the 
world. Dominating polymers include polypropylene, polyvinylchloride, polystyrene, etc., that are 
typically used for making plastics [55, 150]. Due to high durability and inexpensiveness, plastics 
are very useful for human society and virtually used in every aspect of daily life. The demand for 
polymers synthesis, therefore, has been increasing. However, current polymers are typically 
derived from finite resources of petrochemicals [1, 2]. As predicted from current usage rate of 
fossil fuels, fossil fuels are likely to go extinct [3]. Thus, current polymer production is not 
sustainable. Additionally, current disposal rate of polymer-derived products presents certain 
environmental challenges. ‘White pollution’ involves the accumulation of plastic product in the 
environment [57]. It can impose detrimental effects in the environment due to its durability and 
practically difficult to regulate the production and disposal. Thus, biodegradable polymers 
synthesis that is both cost-effective and sustainable is desired, and scientific efforts to replace 
current petroleum-derived polymer production expanded greatly over last few decades [58, 
151]. 
  Recently, scientists turned to microbial engineering to utilize fermentation process for 
fuels and chemical production. Some of the visionaries include utilization of renewable 
resources and produce fuels and chemicals eventually replacing current fossil fuel-based 
processes. These efforts eventually led to utilizing fermentation products to synthesize bio-
based, degradable polymers. The most noted examples include poly(lactide) (PLA) synthesis 
from fermentation product lactic acid, poly(butylene succinate) (PBS) from succinate and bio-
polyethylene from ethanol [61, 152, 153]. However, despite successful polymer synthesis from 
renewable resources, inflexibility of these bio-based polymers cannot possibly accommodate all 
the existing plastic market requiring various characteristics. Consequently, need to diversify the 






polymer synthesis from non-fossil fuel system is desired. Particularly, as demonstrated with PLA 
and PBS synthesis, various monocarboxylic or dicarboxylic acid based polymer synthesis 
gained significant interests [58, 151]. Microorganisms naturally produce a variety of organic 
acids as their metabolic products and can be genetically engineered to improve production. 
Also, although all acids commonly share carboxyl group at the end of the chain, structures and 
chain lengths of each organic acid differ allowing variable characteristics of resulting polymers 
[154]. Due to these advantages, polymer synthesis from microbial organic acids is highly 
desirable.  
 Saccharomyces cerevisiae is a robust, instrumental yeast for baking, brewing and 
bioethanol production and signified as a model eukaryote in molecular and cellular biology. 
Extensive studies of S. cerevisiae allowed the establishment of the elaborate metabolic system, 
therefore, it may be an ideal candidate for genetically engineering to produce valuable fuels and 
chemicals. However, despite its well-known metabolism, their metabolite product accumulation 
other than alcoholic fermentation is relatively unknown. Hence, I investigated S. cerevisiae 
metabolites produced during fermentation under various conditions to identify potential 
monomer candidates for polymer synthesis. Among many metabolites, I observed significant 
amounts of 2-isopropylmalate (2-IPM) accumulation, an intermediate of leucine biosynthesis, 
during defined medium fermentation. I spotted the 2-IPM production only occurs with leucine 
auxotrophic strain, commonly used an auxotrophic marker in yeast for engineering purposes 
agreeing with previous studies [155]. The 2-IPM is a 4-carbon chain dicarboxylic acid with 
isopropyl group at alpha (second) carbon. I predicted the structure of 2-IPM is a suitable and 
novel monomer candidate for bio-based polymer synthesis. Thus, in this study, I metabolically 
engineered S. cerevisiae strain for overproduction of 2-IPM and demonstrated synthesis of bio-
based polymer synthesis from 2-IPM. To my knowledge, this study is the first attempt for 
genetically engineering yeast to overproduce 2-IPM, and the attempted to synthesize polymer. 
   
6.2 Materials and methods 
Strains, medium and culture conditions 
S. cerevisiae strains used in this study were summarized in Table 6.1. Yeast cells were 
routinely cultured in the Yeast extract-peptone and glucose (YPD, 10 g/L yeast extract, 20 g/L 
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peptone, and 20 g/L glucose) medium to prepare initial inoculum at 30°C with 250 rpm agitation 
speed. Various yeast defined medium (Yeast nitrogen base only (YNB), Synthetic complete 
(SC) and Verduyn medium [156]) were used in fermentation experiments. YNB medium 
contained 6.7 g/L yeast nitrogen base with ammonium sulfate, and SC medium contained 6.7 
g/L yeast nitrogen base and 0.79 g/L complete supplement mixture (CSM) (Bio 101, Vista, CA). 
Modified Verduyn medium 15 g/L (NH2)2SO4, 8.0 g/L KH2PO4, 3.0 g/L MgSO4, 10 mL/L trace 
element and vitamin solution 12 mL/L. Trace element contained 15 g/L EDTA, 5.75 g/L ZnSO4, 
0.32 g/L MnCl2, 0.50 g/L CuCl2, 0.47 g/L CoCl2, 0.48 g/L Na2MoO4, 2.9 g/L CaCl2 and 2.8 g/L 
FeSO4. Vitamin solution contained 0.05 g/L biotin, 1.0 g/L calcium pantothenate, 1.0 g/L 
nicotinic acid, 25.0 g/L myo-inositol, 1.0 g/L thiamine hydrochloride, 1.0 g/L pyridoxal 
hydrochloride and 0.2 g/L p-aminobenzoic acid [156]. pH of all media was adjusted to 5.8.  
leucine was added at 0.1 g/L for standard (1x) concentration otherwise indicated for 
supplemented concentration. Glucose was used as a carbon source for all yeast cultivation. To 
select yeast transformants carrying NAT1, HyB, KanMX, resistance gene, 120 µg/mL of 
nourseothricin, 300 µg/mL of Geneticin G418 and 300 µg/mL of hygromycin was used, 
respectively. Escherichia coli TOP10 was cultivated in the Luria-Bertani medium at 37°C with 
250 rpm agitation speed, and 50 µg/mL of ampicillin was added for selection of plasmid-carrying 
cells.  
Plasmid construction 
All primers, template plasmids, and constructed plasmids are listed in Table 6.1, and 2. 
expressing plasmids used in this study are based on pRS series vectors with an antibiotic 
marker (Table 6.1, [141]). The guide RNA(gRNA) targeting LEU1, LEU2, URE2, LEU4 and 
intergenic site (CS6, S. cerevisiae chromosome VII) were synthesized by gBlock from IDT Inc. 
or by PCR. The gBlocks for gRNAs were synthesized with the recognition site of each gene and 
flanking sequences for SacI and KpnI restriction enzyme digestion. Then gBlocks and pRS42K 
and 42H vector plasmids were digested with SacI and KpnI enzyme. Resulting gBlocks and 
vectors were ligated. The resulting ligated vectors and inserts were transformed into E. coli for 
plasmid amplification.  
CRISPR/Cas-based genome editing for strain engineering 
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CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-
Associated Proteins) based genome editing system was for all strains engineering. Previously 
established technique in our lab was used [67, 132]. The pRS42N Cas9 plasmid was 
transformed into S. cerevisiae strain first then Cas9 carrying strain was used as host strain for 
further genetic modifications. Plasmid carrying guided RNA for LEU1, LEU2, LEU4, URE2 and 
intergenic site CS6 with the double stranded repairing donor DNA were transformed into Cas9 
carrying strains. All transformation method was adapted from PEG-LiAc high-efficiency yeast 
transformation method [133] and selected on yeast extract-peptone (YP) medium with 20 g/L of 
glucose and with appropriate antibiotic markers. All strains and plasmids used in the study are 
listed in Table 6.1 and primers are listed in Table 6.2. 
Fermentation experiments 
To prepare yeast strains for fermentation experiments, yeast cells were cultivated in 
YPD medium at 30°C and 250 rpm. Cells were harvested at exponential phase by centrifugation 
and washed two times with sterile water. Flask-scale Fermentation experiments were performed 
in SC, YNB and Verduyn media with 80 g/L glucose. All flask-scale fermentation experiments 
were performed in 50 mL culture using a 250 mL Erlenmeyer flask tightly covered with 
aluminum foil at 30°C and 100 rpm of rotation speed.  Initial cell densities of all fermentation 
experiments were adjusted to OD600 of 1.  All flask-scale fermentation experiments were 
performed in duplicates. 
The glucose-limited fed-batch culture was conducted in BioFlo & CelliGen 310 fermentor 
(New Brunswick Scientific-Eppendorf, Enfield, CT, United States) with the 1-liter culture of 
modified Verduyn media and 40 g/L of glucose. Initial cell densities were adjusted to OD600 and 
pH was maintained at 5.8 with 5N NaOH. When glucose was depleted, feeding media solution 
was started containing: 9.0 g/L KH2PO4, 2.5 g/L MgSO4, 3.5 g/L K2SO4, 0.28 g/L Na2SO4, 600 
g/L glucose, 10mL/L trace element solution, 12mL/L vitamin solution [156] and 10 g/L Leucine. 
Feeding rate was adjusted accordingly to growth rate.  
Analytical methods 
Cell growth was monitored by measuring optical density (OD) at 600nm using a UV-
visible spectrophotometer (Biomate5, Thermo, Rochester, NY).  Glucose, acetate, 2-isopropyl 
malate and ethanol concentrations were determined by high-performance liquid 
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chromatography (HPLC, Agilent Technologies 1200 Series, Mississauga, CA) equipped with a 
refractive index detector using a Rezex ROA-Organic Acid H+ (8%) column (Phenomenex Inc., 
Torrance, CA). The column was eluted with 0.005 N of H2SO4 at a flow rate of 0.6 mL/min at 
50°C.  
Purification of 2-IPM from fermentation broth 
Solvent extraction and crystallization method adapted and modified from US Patent 
4,407,953 [157] was used to purify 2-IPM. At the end of the fermentation, yeast cells were 
separated from the broth via centrifugation. The fermentation broth was concentrated by boiling 
and evaporating to about a fifth of its original volume. The pH of concentrated fermentation 
broth was adjusted to 1.5 with sulfuric acid then an equal volume of methyl ether ketone (MEK) 
was added. After a vigorous mixing, aqueous phase and solvent phase were separated by the 
separatory funnel, and 2-IPM remained in solvent phase. Extraction of 2-IPM with MEK was 
repeated one more time with remaining aqueous phase. The solvent phases were combined 
and allowed for evaporation until dissolved 2-IPM crystallized. 2-IPM crystals were separated 
and washed with ice-cold water until impurities were not detected.  
Identification of 2-IPM by GC-MS  
Gas chromatography-mass spectrometry was initially used for identification of 2-IPM. The 2-
IPM is containing fermentation broth sample vacuum dried and derivatized by 
methoxyamination and silylation method as described previously [158]. 5 uL of methoxyamine 
hydrochloride in pyridine (40mg/mL) solution was added to 2-incubated at 30˚C and 400 rpm for 
90 minutes. Then, 45uL of N-methyl-N-trimethylsilyl trifluoroacetamide (MSTFA) was added and 
incubated at 37˚C and 400 rpm for 30 minutes. The derivatized 2-IPM sample was analyzed by 
GC-MS (Agilent Technologies Inc., CA; 7890 Gas chromatography and 5975 MSD) and NIST 
library as well as a comparison to 2-IPM standard chemical (Sigma). 
Polymer synthesis of 2-IPM 
 Purified 2-IPM was treated with acetic anhydride and sodium acetate for 3.5 hours, 
losing hydroxyl group at carbon 2 and producing cyclic form. Reaction method is used as 
previously described. [159]. Than 2-IPM anhydride monomer was reacted with epichlorohydrin 
to form polymers with catalysts in solvents at 45°C for about 15 hours. The method was adapted 





2-isopropylmalate (2-IPM) production by leucine auxotrophic strain 
Initially, I performed glucose fermentation of S. cerevisiae strains under defined medium 
(SC) to observe the phenotypes and fermentation metabolite production. The prototrophic strain 
S288C and its auxotrophic derivative BY4742 was used for growth and analyses their 
fermentation metabolites. Overall, S288C had faster fermentation rate and higher biomass 
accumulation as compared to BY4742 strain under SC medium (data not shown). Overall 
metabolites were very similar but few significant differences in extracellular metabolite 
accumulation detected by HPLC. First, acetate production by BY4742 was notably higher than 
S288C. Secondly, unknown metabolite was detected by HPLC at retention time around 6.6 min 
only in BY4742 strain at a significant level (Figure 6.1A). To identify the unknown metabolite, I 
analyzed the fermentation broth sample of S288C and BY4742 with GC-MS. Initial analysis 
indicated 2-isopropylmalate (2-IPM) was a major difference between S288C and BY4742 strain. 
To confirm, the 2-IPM standard chemical analysis in HPLC and GC-MS was performed. Since 
2-IPM is an intermediate of leucine biosynthetic pathway, the 2-IPM production is likely caused 
by leucine auxotrophy of BY4742 by ΔLEU2 (Figure 6.2). However, metabolic pathway shows 
end-product of ΔLEU2 is 3-isopropylmalate (3-IPM). To further confirm 2-IPM production, not 
the 3-IPM production I deleted each LEU1 and LEU2 in S288C (SL1 and SL2 strain, 
respectively) and compared for 2-IPM production. Figure 6.1C shows 2-IPM production occurs 
in both SL1 and SL2 strain. 
Metabolic engineering of leucine auxotrophic strain for higher 2-IPM yield  
 After validating 2-IPM accumulation in ΔLEU1 strain (SL1), I attempted to engineer the 
pathway of SL1 further to increase 2-IPM yield. The SL1 strain can accumulate ~0.5 g/L of 2-
IPM fermenting 80 g/L of glucose (~0.007 g/g yield, Figure 6.1C), showing much room for 
improvement. First, I identified URE2 as a target of deletion. The URE2 gene in S. cerevisiae 
encodes Ure2p that plays an important role nitrogen catabolite repression transcriptional 
regulator. Thus, deletion of URE2 will relieve the nitrogen catabolite repression during amino 
acid (leucine) supplemented medium [161]. As shown in Figure 6.3A, URE2 deletion strain 
(SUL) produced higher 2-IPM yield compared to SL1 strain (~0.01 g/g vs. ~0.007 g/g).  
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Next, I targeted for increasing pyruvate flux to branched amino acid biosynthetic 
pathway and removal of leucine feedback inhibition. Although pyruvate is a key intermediate 
involved in several metabolic pathways and yet, native yeast mostly convert pyruvate into 
acetaldehyde to produce ethanol under fermentative growth condition. Thus, acetolactate 
synthase converting pyruvate to 2-aceto-lactate was targeted for overexpression (for example, 
Bacillus subtilis AlsS [162]). Also, yeast metabolism tightly regulates amino acid synthesis by 
feedback regulation. To remove leucine feedback inhibition, LEU4 was targeted to mutate 
leucine feedback inhibition residue (Asp578) as previous research identified [163]. Each and 
both BsAlsS and mLEU4 (Asp578 changed to Tyr578) were introduced into SUL strain resulting 
in SUAL (SUL strain overexpressing BsAlsS), SULL (SUL strain with mLEU4) and SUALL (SUL 
strain overexpressing BsAlsS and mLEU4) strains. Unexpectedly, SUAL and SULL strain did 
not increase in 2-IPM yield (Figure 6.3A). In fact, SULL strain yielded lower 2-IPM compared to 
before the introduction of mLEU4 strain. However, the strain harboring both BsAlsS and mLEU4 
had a two-fold increase in 2-IPM yield achieving highest 2-IPM production among all engineered 
strains in this study. The 2-IPM productivity patterns were consistent to 2-IPM yield, showing 
genetic manipulation increased 2-IPM generally improved overall production as well (Figure 
6.3A and B). 
Fermentation condition optimization for large scale fermentation and purification of 2-
IPM 
 2-IPM production further enhanced as fermentation conditions were optimized. How 
yeast cells cognize the environment, as nutrient-limited or nutrient-rich, especially nitrogen 
sources, can be important for producing amino acid-related products. Thus, different defined 
media with best 2-IPM producing strain (SUALL) were tested for 2-IPM production. SC medium, 
YNB medium and Verduyn medium varying nitrogen source, vitamin, trace elements and amino 
acids were tested with an equal amount of leucine supplementation. As shown in Figure 6.3C, 
YNB and Verduyn media had 1.5-fold higher 2-IPM yield (0.03 g/g) compared to SC medium 
(0.02 g/g). Although both YNB and Verduyn media showed similar yield, however, the 2-IPM 
productivity of Verduyn was higher illustrating that 2-IPM production is most efficient under 
Verduyn medium. Next, different concentrations of leucine supplementation were tested. With 
0.1 g/L as a 1x standard, concentrations of 0.1x, 0.5, 1x and 2x Leucine supplementation were 
tested with Verduyn media. Overall, increasing leucine concentration resulted in higher yield 
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and productivity (Figure 6.3C and D). In sum, SUALL strain with Verduyn media, 2x leucine 
supplementation resulted in highest yield and productivity. 
 After 2-IPM overproducing strains was developed, and optimization of fermentation 
conditions was accomplished, I performed large-scale fermentation (starting at 1 L) to tightly 
control the fermentation parameters such as pH, aeration, and agitation. For batch phase, 
Verduyn medium with 20 g/L glucose and 2x leucine supplementation was used. The cell 
density equivalent of OD 1 was inoculated. Once glucose from batch phase depleted, limited-
glucose fed-batch phase started by feeding concentrated glucose solution by tubes. Cell density 
and glucose accumulation were carefully monitored to minimize overfeeding glucose solution 
thus preventing alcoholic fermentation. At the end of fermentation, ~25 g/L of 2-IPM was 
produced with a culture volume of ~1.5 L with a cell volume of ~100 mL. This result illustrates 2-
IPM at industrial scale is achievable.  
Because there was no 2-IPM product available to purchase at large scale, at the end of 
fermentation, the broth was harvested for purification. The produced 2-IPM was purified using 
solvent extraction by MEK and crystallization. To obtain high purity 2-IPM for polymer synthesis, 
several washing steps were performed yielding ~15 g/L of 2-IPM in the end. 
Polymer synthesis using 2-IPM  
 Based on previous work of malic acid polymerization, 2-IPM was tested for polymer 
synthesis with a similar strategy. First, 2-IPM was dehydrated to lose hydroxyl group at carbon 2 
and become cyclic form to produce 2-IPM anhydride monomer. Two isomers can present 
depending on the location of the double bond (isopropyl group chain or in the ring). Then 2-IPM 
anhydride monomer can react with epichlorohydrin to form polymers at 45°C with a catalyst for 
15 hours. The reaction steps and 2-IPM polymeric structures are illustrated in Figure 6.5. 
 
6.4 Discussion 
 The use engineered microorganisms as a microbial cell factory has been widely adapted 
producing fuels and chemicals envisioning to replace fossil fuel-based production. Recently, the 
idea of extended to synthesize polymers from bio-based chemicals. However, to successfully 
replace current polymer industries, various types of polymer synthesis must be established. 
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Here I demonstrate overproduction of 2-isopropylmalic acid (2-IPM), an intermediate of leucine 
biosynthesis by engineered S. cerevisiae and synthesis of the novel polymer using 2-IPM.  
The native yeast strains can synthesize 2-IPM but do not accumulate at high amounts 2-
IPM. However, with leucine auxotrophy (ΔLEU2 or ΔLEU1), yeast can accumulate 2-IPM under 
glucose fermentation with the minimal medium.  Additionally, when yeast accumulates 2-IPM, 
higher acetate is observed as a signature due to acetyl group of acetyl-CoA is required to 
produce 2-IPM. Anticipating the value of 2-IPM as new monomer material for polymer synthesis, 
I attempted to overproduce 2-IPM by metabolic engineering strategy. The native yeast 
metabolic system tightly regulates amino acid biosynthetic pathway via feedback regulation and 
nitrogen catabolic repression network (Figure 6.2). Also, most sugars are metabolized via 
glycolysis and converted to ethanol under fermentative condition. Thus, several genes were 
identified as a target of genetic manipulation to remove feedback regulation, nitrogen catabolite 
repression (NCR) and increase carbon flux toward 2-IPM synthesis. 
 During culturing of yeast, yeast perceives growth environment as either nutritious or 
starving, depending on nitrogen source availability and quality. Then, via NCR, nitrogen 
catabolic genes are amino acid biosynthesis either activated or repressed. URE2, one of the 
global NCR transcriptional regulator, was first targeted for deletion to remove NCR. URE2 
inhibits GLN3 and GCN4 transcription under rich nitrogen source which activates genes that are 
subject to NCR and amino acid biosynthesis. Thus, I hypothesized deletion of URE2 would 
result in activation of GLN3 and GCN4 consequently activating amino acid biosynthesis (leucine 
biosynthesis) and improve 2-IPM production in leucine auxotrophic strain (SL1). As expected, 
the ΔURE2 in SL1 strain (SUL) increased 2-IPM yield and productivity by ~1.4 fold (Figure 6.3A 
and B).  
With the removal of NCR, increasing pyruvate flux toward leucine biosynthetic pathway 
and removal of leucine feedback inhibition was considered. Because native yeast produces 
ethanol from pyruvate as a major product, increasing pyruvate flux into leucine biosynthetic 
pathway (branched amino acid pathway) is necessary. The heterologous acetolactate synthase 
from Bacillus subtilis (BsAlsS) with constitutive promoter was introduced to SUL strain to avoid 
any transcriptional regulation if native acetolactate synthase (ILV2). For the removal of leucine 
feedback inhibition, a SNP was introduced to native LEU4 resulting in a change of amino acid 
Asp578 to Tyr578 (mLEU4) as the previous study already reported. The LEU4 gene also 
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encodes for 2-IPM synthase converting 2-keto-isovalerate to 2-IPM. Each BsAlsS and mLEU4 
were introduced into SUL strain (SUAL and SULL, respectively) to observe the effect on 2-IPM 
production. Unexpectedly, when BsAlsS or mLEU4 was introduced, 2-IPM production did not 
improve (Figure 6.3 A and B). BsAlsS did not change the yield not the productivity of 2-IPM, and 
the introduction of mLEU4 decreased in 2-IPM production. I speculated increasing pyruvate flux 
had did not help in increasing 2-IPM production because leucine feedback inhibition is present 
making conversion of 2-keto-isovalerate to 2-IPM limiting reaction. Likewise, removal of 
feedback inhibition did not improve 2-IPM production likely due not enough carbon flux toward 
leucine biosynthetic pathway achieved. Hence, both BsAlsS and mLEU4 were introduced to 
SUL strain (SUALL) to observe synergistic effect to overproduce 2-IPM. The 2-IPM yield 
improved significantly (~2-fold increase in yield and productivity from SUL strain, Figure 6.3A 
and B). These data show both ‘push and pull’ was necessary to achieve desired product 
formation. 
After optimizing yeast strains for 2-IPM production, fermentation condition optimization 
was performed with best 2-IPM producing strain. Three conditions varying nutrient composition 
were used (SC, YNB and Verduyn, composition listed in materials and method). Verduyn media 
showed the best 2-IPM production increasing in both yield and productivity (Figure 6.3C and D). 
SC media contains other amino acid mixture whereas YNB and Verduyn media do not. As a 
result, shown in Figure 6.2C, the 2-IPM yield of SC medium lower compared to YNB and 
Verduyn media. This is an indirect evidence of the presence of remaining nitrogen catabolite 
repression other than genes regulated by URE2. Also, 2-IPM productivities were higher with SC 
and Verduyn medium compared to YNB medium. This result show 2-IPM productivities depend 
on nutrient availability. To further optimize, different leucine concentration supplementation was 
tested. Because 2-IPM producing strains are leucine auxotrophic, higher leucine 
supplementation increased 2-IPM yield and productivities in general. In sum, Verduyn media 
with 2x leucine supplementation showed best 2-IPM yield and productivity (0.033 g/g and 0.11 
g/L/H).  
To illustrate 2-IPM production at industrial scale, limited glucose fed-batch fermentation 
using bioreactor was performed. Tightly controlling fermentation parameters, maintaining pH at 
5.8 and high aeration to prevent alcoholic fermentation much as possible, 25 g/L of 2-IPM was 
achieved (Figure 6.4B). After illustrating overproduction of 2-IPM by engineered yeast, 
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purification of 2-IPM from fermentation broth was attempted. Due to low demand of the 
chemical, 2-IPM was unavailable for large-scale purchase that is necessary for investigating 
polymer synthesis by 2-IPM. Using solvent extraction by MEK and crystallization, I obtained 15 
g/L of 2-IPM powder with 99% purity. The resulting high-pure 2-IPM was then dehydrated to 
form anhydride monomer and polymerized with an epoxide. The predicted characteristics of the 
2-IPM based polymer are a biodegradable elastomer. Further 2-IPM-derived polymer 
characterization is currently under investigation. 
In conclusion, I successfully overproduced 2-IPM by metabolically engineering yeast 
from initial 2-IPM accumulation observation. To my knowledge, this is first report attempting to 
engineering yeast strains to overproduce 2-IPM. Further, 2-IPM was successfully purified with 
high purity, and polymer synthesis was attempted. Detailed 2-IPM-derived polymer 
characterization is currently under investigation. With success of 2-IPM-derived polymer 
synthesis, I anticipate various application can be achieved possibly replacing part of the current 









Figure 6.1 Identification and confirmation of 2-IPM accumulation by leucine auxotrophic strains. 
(A) HPLC chromatogram comparison of BY4742 (leucine auxotroph, red line) and S288C 
(prototroph, green line) after glucose depletion. Acetate (B) and 2-IPM (C) yield from 80 g/L 


















Figure 6.2 Leucine biosynthesis pathway from glucose.  Glucose is first converted to pyruvate 
via glycolysis. Pyruvate can be converted to acetaldehyde for ethanol or acetate production for 
ethanol and acetate production and 2-aceto-lactate entering leucine biosynthetic pathway. 
Acetate is converted to acetyl-CoA which combines with 2-keto-isovalerate to produce 2-IPM. 
Inhibitory regulation is shown by a dotted line, and activation regulation is shown with solid line. 
LEU2, 3-isopropylmalate dehydrogenase; LEU1, isopropylmalate isomerase; URE2, nitrogen 
catabolite repression transcriptional regulator; ILV2,6, acetolactate synthase, and regulatory 







Figure 6.3 Fermentation profiles of engineered strains and different fermentation media 
conditions. (A-B) 2-IPM yield (A) and productivity (B) of all engineered strains for improving 2-
IPM production.  SL1, SUL, SUAL, SULL and SUALL strains were compared under SC medium 
with 80 g/L glucose. (C-D) Different defined medium fermentations were compared for improved 
2-IPM yield (C) and productivity (D). SC, YNB and Verduyn media and different concentrations 
of leucine supplementation were tested with SUALL strain.   
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Figure 6.4 Yields, productivities, and yield and productivity comparison of 2-IPM accumulation. 
All engineered strains and different fermentation medium conditions were compared.  (A)Yields 
and (B) productivities of 2-IPM were calculated based on the amount of consumed glucose and 
last time point of fermentation. (C) Yield and productivities (from (A and B)) were compared 























































Figure 6.5 Polymerization steps using 2-IPM as a starting material. 2-IPM Anhydride monomer 
can be synthesized by dehydration with acetic anhydride and sodium acetate losing hydroxyl 
group at carbon 2 and closing to for cyclic form. Then 2-IPM anhydride monomer was reacted 







1) 2-IPM Anhydride synthesis












Table 6.1 The list of plasmids and S. cerevisiae strains used in this study 
  
Strain/Plasmid Relevant characteristic(s)/Description Source or Reference 
BY4742 strains 
BY BY4742 MATα leu2 his3 lys2 ura3  
S288C strains 
S288C MATα  
SL2 MATα ΔLEU2 This study 
SL1 MATα ΔLEU1 This study 
SUL MATα ΔLEU1 ΔURE2 This study 
SUAL MATα ΔLEU1 ΔURE2 CS6::BsAlsS This study 
SULL MATα ΔLEU1 ΔURE2 mLEU4 This study 
SUALL MATα ΔLEU1 ΔURE2 mLEU4 CS6::BsAlsS This study 
Plasmids 
pRS405 LEU2, 2μ origin, Ampr  plasmid EUROSCARF 
pRS42N NAT1 marker plasmid EUROSCARF 
pRS42K KanMX marker plasmid EUROSCARF 
pRS42H HyB marker plasmid EUROSCARF 
pRS42N Cas9 PPGK -MCS- TCYC,  Cas9 expression plasmid [67] 
pRS42K gRNA URE2 URE2 gRNA plasmid This study 
pRS42H gRNA LEU2 LEU2 gRNA plasmid [67] 
pRS42H gRNA LEU1 LEU1 gRNA plasmid This study 
pRS42K gRNA LEU4 LEU4 gRNA plasmid This study 
pRS42H gRNA CS6 CS6 intergenic site gRNA plasmid This study 
pRS426 BsAlsS pRS426 GPDp-alsS-CYC1t [162] 
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Table 6.2 Primers used in this study 
 
  
Primers Sequence Description 
JIN4360 AGCAATATATATATATATATTTCAAGGATATACCATTCTACATAAACGCCAGGTTGTGTC ∆LEU2 
donor JIN4361 TAAAGTTTATGTACAAATATCATAAAAAAAGAGAATCTTTGACACAACCTGGCGTTTATG 
JIN4318 TGGTTAGCAATCGTCTTACTTTCTAACT ∆LEU2 




JIN5421 TTTTGTCGCTATCGATTTTTATTATTTGCTGTTTTAAATCCATAAACGCCAGGTTGTGTC ∆LEU1 
donor JIN5422 CATGTTATTGACGCCAGGTTTGGACGTTGTTTTTCACTGTGACACAACCTGGCGTTTATG 
JIN5423 CTTATTTAAACAGCAGAACTTAACT ∆LEU1 




JIN3743 GTTTTTCATTTTTTGTTATTAGTCATATTGTTTTAAGCTGCAAATTAAGTTGTACACCAAAGGCTGCTTTAAAAAC ∆URE2 
donor JIN3744 ACATACCCTTATAACCTTCTTTTCCTCCTTCTTCTTTCTTTCTTGTTTTTAAAGCAGCCTTTGGTGTACAACTTAA 
JIN3716 GAATACCGACTGTTGTCTGG ∆URE2 
confirm JIN3717 CATATCTCGACATCAATCG 
JIN5425 TGAAGAATCACCGACATCTT GTTTTAGAGCTAGAAATAGCAAG 
LEU4 gRNA 
JIN5426 TGAAGAATCACCGACATCTTGTTTTAGAGCTAGAAATAGCAAG 
JIN5427 AAGATGTCGGTGATTCTTCAGATCATTTATCTTTCACTGCGGA mLEU4 
donor JIN5428 CGTAATGCCGACAACGAAAAGGCCTACAAATGGGGTGTAGGTGTCTCAGAATATGTCGGT 
JIN4319 TCTACGGTAGCAGGTAAGTTGAAAAT mLEU4 
confirm JIN4320 TTCTAGCGCCGTTCAAGACCAT 
SOO587 AACCTCGAGGAGAAGTTTTTTTACCCCTCTCCACAGATCCAGGAAACAGCTATGACCATG CS6 intergenic 
site-M13 SOO588 TAATTAGGTAGACCGGGTAGATTTTTCCGTAACCTTGGTGTCTGTAAAACGACGGCCAGT 
SOO595 GTCTGCCGAAATTCTGTG CS6 site 
integration 
confirm SOO596 CGGTCAGAAAGGGAAATG 
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Chapter VII: Potential Applications of 2-IPM: Novel Skin-Brightening Agent6 
 
7.1 Introduction 
 Skin-brightening agents are highly demanded in cosmetic industries especially in skin-
care products due to driving force of desiring for brighter and clearer skin. Skin-care products 
containing skin-brightening agents can be readily found in the market and the demand it is 
increasing. In severe cases, skin-brightening agents demanded to treat abnormal 
hyperpigmentations such as melasma or any other forms of melanin hyperpigmentation. 
Responding to this high demand, many skin-brightening agents were discovered in past few 
decades. For example, arbutin, a naturally occurring beta-D-glucopyranoside of hydroquinone is 
known for its effectiveness for skin depigmentation capability [164]. However, recent studies 
proposed potential carcinogenicity of beta-arbutin [165, 166]. Thus, usage of beta-arbutin in 
cosmetic products in Europe is prohibited. Thus, increasing number of studies are investigating 
to discover novel skin- brightening agents.  
The primary mechanism of skin-brightening is to inhibit melanin synthesis. To do this, 
rate-limiting tyrosinase enzyme inhibition is effective to control the melanin production. 
Tyrosinase is a copper-containing enzyme, which requires copper ion as a cofactor. 
Consequently, lowering copper ion availability can effectively inhibit tyrosinase activity [167-
169]. Therefore, organic acids, generally metal chelators, can be used as the novel skin-
brightening agent. Also, effectively chelate copper ions and inhibit tyrosinase activity, organic 
acids should be transported into the cell where melanin synthesis takes place [170]. However, 
organic acids cannot be transported into the readily due to the dependence of pH and polarity. 
Hence, the skin-brightening agent should be able to enter the cell and inhibit the tyrosinase 
activity.  
 A previous study (Chapter VI) reports overproduction of 2-isopropylmalate (2-IPM) from 
engineered yeast. The 2-IPM is producing yeast accumulated 2-IPM up to 25 g/L during 
fermentation. From this result, I inferred superior cell permeability of 2-IPM compared to other 





organic acids. Thus, this study investigates the skin-brightening capability of 2-IPM by 
examining tyrosinase inhibitory activity in both in vitro and in vivo system.  
 
7.2 Material and Method 
In vitro tyrosinase inhibition assay 
 The sample solutions (Arbutin, malic acid, and 2-IPM) was dissolved in sterile pure water 
and prepared to have final concentrations of 50, 40, 30, 20, 10mM. Following ingredients were 
added to each well to 96 well microplate in order of 220 μL 0.1M phosphate buffer (pH 6.5), 20 
μL sample solution or buffer as a control 40 μL mushroom tyrosinase and 40 μL 1.5 mM 
tyrosine. The microplate was incubated at 37°C for 20 minutes, and the absorbance at 490nm 
using microplate reader was recorded. 
Intracellular detection of 2-IPM and malic acid 
 To test cell permeability of 2-IPM and malic acid, yeast S288C was used. 100mM of 2-
IPM and malic acid solutions, adjusting pH to 4.0, 5.0 and 6.0 were prepared in a buffer. Cell 
density equivalent to OD600 20 was inoculated to 2mL solutions and incubated at 30°C with 250 
rpm agitation speed for ~10 hours until both 2-IPM and malic acid concentrations were 
detected. 
Cytotoxicity of 2-IPM 
 Effect of 2-IPM on cell viability of B16F10 (ATCC® CRL-6475™) cells was tested. 2-IPM 
concentrations of 0, 0.5, 1, 2, 4, 8, and 10 mM were used. 2-IPM samples were treated for ~five 
days, and cell viability was calculated by % viable cells to the untreated group.  
α-MSH-induced melanogenesis 
 To all B16F10 cell samples, 100 nM of α-MSH was treated to induce melanogenesis.  
Then 100 or 200 μM Arbutin or 1, 2, or 4 mM 2-IPM was treated. Samples were incubated for 





  To observe potentials of 2-IPM as a depigmenting agent, in vitro tyrosinase inhibitory 
activity was tested. As a positive control, arbutin was used, and as a structural control to 2-IPM, 
malate was used. Although tyrosinase inhibitory activity was observed in all samples, the 
inhibitory activity of arbutin was superior compared to malate and 2-IPM in any concentrations 
(Figure 7.1). The inhibitory effect of malate and 2-IPM was similar. Although overall tyrosinase 
inhibitory activity was lower with 2-IPM, I hypothesized 2-IPM can be still effective based on 
previous speculations of 2-IPM structure and cell permeability. To observe relative cell 
permeability, laboratory yeast strain, S288C was incubated with 100mM of 2-IPM or malate or 
water at different pH. Then, cells were harvested, lysed for intracellular 2-IPM or malate 
detection. As shown in Figure 7.2, 2-IPM had significantly higher 2-IPM accumulation compared 
to malate.  
 After in vitro tyrosinase inhibition was measured, in vivo test was performed with mouse 
skin melanoma cell, B16F10. First, cytotoxicity of 2-IPM was tested. B16F10 cells were treated 
with 2-IPM concentration ranging 0-10 mM. The cell viability was compared to untreated group 
and % cell viability was calculated. 2-IPM did not show cell cytotoxicity up at four mM. However, 
the toxicity started to show from 8- 10 mM displayed at lower cell viability (Figure 7.3). Thus, 2-
IPM concentration from 8 mM and higher was excluded from the further experiments. Next, the 
effect of 2-IPM on α-MSH-induced melanogenesis in B16F10 cells was observed (Figure 7.4). 
B16F10 cells can produce melanin only with α-MSH induction. Thus, treating the cell with α-
MSH and sample of interest can illustrate effects of melanin synthesis by various samples. The 
first and second column shows α-MSH induction is necessary for melanin synthesis. Arbutin 
was treated with 100 or 200 μM as a control. At both concentrations, extracellular melanin 
concentration decreased, but intracellular melanin decreased significantly only with 200 μM. For 
2-IPM samples, 1, 2 and four mM concentrations were tested. At one mM, melanin synthesis by 
α-MSH induced B16F10 was not inhibited indicated by high melanin synthesis. However, both 2 





 As demand to find novel skin-brightening agents are increasing, I investigated the 
potential skin-brightening effect of 2-IPM by observing tyrosinase inhibitory activity in this study. 
From the in vitro tyrosinase inhibitory activity assay, 2-IPM showed some inhibitory activity as 
shown in Figure 7.1. However, compared to the positive control, arbutin, 2-IPM had significantly 
lower tyrosinase inhibitory activity at all concentrations tested. Additionally, malate (malic acid) 
was used as a structural control to 2-IPM, and tyrosinase inhibitory of 2-IPM and malate was 
similar. 
 Although tyrosinase activity of 2-IPM was lower than the positive control arbutin, I 
hypothesized 2-IPM still can be a good skin-brightening agent. A previous study (Chapter VI) 
reports overproduction of 2-IPM in engineered yeast up to 25 g/L indicating secretion of 2-IPM is 
not a limiting. Typically, transport of charged molecules such as organic acids heavily depended 
on surrounding pH and known as one of the bottlenecks for overproducing in the microbial 
system. However, 2-IPM production in yeast had no apparent inhibition of secretion. Thus, cell 
permeability of 2-IPM can be better compared to other organic acids. It is advantageous to have 
better permeability as a skin-brightening agent because tyrosinase activity or melanin synthesis 
occurs inside the cell. To test relative cell permeability, yeast cells were inoculated in either 2-
IPM and malic acid at various pH ranges, and intracellular accumulation was observed. As 
shown in Figure 7.3, intracellular 2-IPM accumulation was superior compared to malic acid at 
any given pH. The result indicates 2-IPM has relatively good cell permeability.  
 Next, in vivo tyrosinase inhibition activity assay was performed by measuring 
extracellular and intracellular melanin contents of the B16F10 cells. Four mM of 2-IPM was 
tested as the highest sample concentration due to a possible cell cytotoxicity with 
concentrations higher than four mM (Figure 7.3). At a 2-IPM concentration of 2 mM, both 
extracellular and intracellular melanin concentration decreased demonstrating effective 
inhibition 2-IPM on melanogenesis. Although the effective 2-IPM dose compared to arbutin was 
about 10-fold higher, arbutin is potentially carcinogenic (Figure 7.4). In Europe, for example, 
prohibited usage of arbutin in any cosmetic products. Thus, I compared other commonly known 
skin-brightening agents in the literature. Though various system and concentration were used, 
common skin-whitening agents such as ascorbic acid derivatives (Ethyl ascorbyl ether, ascorbyl 
glucoside, magnesium ascorbyl phosphate, ascorbyl tetraisopalmiate, etc.) and niacinamide, 
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had an effective concentration typically ranging from around 100 μM to 30 mM for ascorbic acid 
derivatives and 1 mM to 5 mM for niacinamide [171-174]. Therefore, 2-IPM is a competitive 
compared to ascorbic acid derivatives and niacinamide as a skin-brightening agent. 
In summary, I investigated the potential of 2-IPM as a novel skin-brightening agent. Due 
to superior relative cell permeability, 2-IPM can be an effective skin-whitening agent, and 
effective doses are comparable to current commercialized skin-brightening agents. Thus, further 
investigation of skin-brightening effect on human skins should be pursued, and I anticipate 2-










Figure 7.1 Tyrosinase inhibitory activity of arbutin, malate, and 2-IPM. Various concentrations of 
chemicals were tested.   
 
  

















































Figure 7.2 Intracellular detection of 2-IPM and malate. Strains were incubated with either water, 



























Figure 7.3 Cytotoxicity of 2-IPM on B16F10 cell. Various concentrations of 2-IPM were tested 






































Figure 7.4 Effect of 2-IPM on α-MSH-induced melanogenesis in B16F10 cells. Cells were 
induced for melanogenesis by α-MSH and treated with either arbutin or 2-IPM. After five days of 
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Chapter VIII: Summary and Future Studies 
 
8.1 Summary 
Microbial engineering to produce valuable fuels and chemicals have been gained 
considerable attention as a sustainable alternative solution to current energy and chemical 
synthesis. To make this option sustainable, feasible, and environmentally friendly, it is essential 
to develop an engineered microbial strain that can utilize renewable feedstocks such as 
lignocellulosic biomass. Lignocellulosic biomass can be broken down to several sugars (mainly 
xylose and cellobiose) that can be used for microbial fermentations. However, cellobiose and 
xylose cannot be assimilated by the industrial microorganisms, such as traditional industrial 
yeast Saccharomyces cerevisiae. To utilize cellobiose or xylose for the fuel and chemical 
production by S. cerevisiae strains, heterologous expression of cellobiose or xylose 
metabolizing genes are required. Thus, the initial study of this dissertation investigates on 
developing optimal yeast strains for utilizing renewable resources (cellobiose, xylose, and 
galactose) and underlying mechanism for efficient fermentation.  
First, the cellobiose fermentation in engineered S. cerevisiae was investigated (Chapter 
II). S. cerevisiae can be engineered to ferment cellobiose by expressing a cellodextrin 
transporter and cellobiose hydrolyzing enzyme. Two cellodextrin transporters (CDT-1 and CDT-
2) were previously identified in N. crassa, but their kinetic properties and efficiency for cellobiose 
fermentation have not been studied in detail. In this study, CDT-1 and CDT-2, which are 
hypothesized to transport cellodextrin with distinct mechanisms, were introduced into S. 
cerevisiae along with an intracellular β-glucosidase (BGL). Cellobiose transport assays with the 
resulting strains indicated that CDT-1 is a proton symporter while CDT-2 is a simple facilitator.  
A strain expressing CDT-1 and GH1-1 (DBT-1) showed faster cellobiose fermentation than the 
strain expressing CDT-2 and GH1-1 (DBT-2) under various culture conditions with different 
medium compositions and aeration levels. While CDT-2 is expected to have energetic benefits, 
the expression levels and kinetic properties of CDT-1 in S. cerevisiae appears to be optimum for 
cellobiose fermentation. These results suggest CDT-1 is a more effective cellobiose transporter 
than CDT-2 for engineering S. cerevisiae to ferment cellobiose. 
However, regardless of enhanced cellobiose fermentation by CDT-1, I investigated CDT-
2 transporter further due to its potential advantage (Chapter II). Heterologous expression of 
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cellobiose metabolizing enzymes requires extra energy for S. cerevisiae. The passive CDT-2 
transporter does not require energy whereas active CDT-1 transporter requires energy. This 
suggests that the CDT-2 might be engineered to provide energetic benefits over the active 
transporter in cellobiose fermentation. I, therefore, attempted to improve cellobiose transporting 
activity of CDT-2 through laboratory evolution. Nine rounds of a serial subculture of S. 
cerevisiae expressing CDT-2 and cellobiose phosphorylase (less ATP-requiring enzyme 
compared to BGL), on cellobiose led to the isolation of an evolved strain capable of fermenting 
cellobiose to ethanol 10-fold faster than the original strain. After sequence analysis of the 
isolated CDT-2, a single point mutation on CDT-2 (N306I) was revealed to be responsible for 
enhanced cellobiose fermentation. Also, the engineered strain expressing the mutant CDT-2 
with cellobiose phosphorylase showed a higher ethanol yield than the engineered strain 
expressing CDT-1 and intracellular β-glucosidase under anaerobic conditions, suggesting that 
CDT-2 coupled with cellobiose phosphorylase may be better choices for efficient production of 
cellulosic ethanol with the engineered yeast.  
After investigation of cellobiose fermentation, xylose fermentation in S. cerevisiae was 
studied in Chapter IV. Previously, improved xylose-fermenting S. cerevisiae strains were 
developed. However, the efficiency of xylose utilization can be improved further. With an 
assumption that xylose fermentation phenotype is complex, QTL analysis approach was taken. 
Two strains harboring different xylose fermentation capability (S288C X123 and JAY291 X123), 
were crossed and recombinant segregants were obtained. The pool of segregants was grown 
under xylose condition to enrich the superior xylose fermenters. Then the whole genome of the 
population was mapped, and QTL analysis was performed. Although clear QTL peaks were 
identified, however, genes affecting xylose fermentation were not discovered.  
 In Chapter V, enhanced glucose and galactose fermentation were achieved by 
screening and investigating the 50 gene targets related to glucose sensing, signaling 
transduction, metabolism and stress responses. Initially, ΔTPS1 strains showed enhanced 
glucose and galactose fermentation. However, this observation led to the prediction of presence 
suppressor mutation because previous research reported lethality of ΔTPS1 under glucose 
condition. By whole genome sequencing, I found one mutation at HXK2 (mHXK2) rescued the 
ΔTPS1 lethality. Also, mHXK2 changed the glucose repression phenotype. In the end, both 
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mHXK2 and ΔTPS1 allowed enhanced glucose or galactose utilization and mixed sugar 
fermentation. 
 The second part of this dissertation focuses on the production of value-added chemicals. 
Specifically, novel organic acid production was investigated (Chapter VI). 2-isopropylmalate (2-
IPM), an intermediate of leucine biosynthesis, was observed by leucine auxotrophic strain. 
Because organic acids are highly valuable to the industries for their diverse usage, S. cerevisiae 
strain was metabolically engineered to overproduce 2-IPM. ΔLEU1 was required to accumulate 
2-IPM initially, URE2 was deleted to remove nitrogen catabolite repression, a mutation at LEU4 
was introduced to remove leucine feedback inhibition, and BsAlsS was expressed for enhanced 
pyruvate flux to leucine biosynthetic pathway. The resulting engineered strains produced 25 g/L 
glucose under limited glucose fed batch fermentation. There is no apparent usage of 2-IPM. 
Thus, potential applications were investigated to synthesize biodegradable polymer and skin-
brightening agent (Chapter VII). 
8.2 Future research directions 
 Although this dissertation provides advances in using engineered yeast to produce 
value-added fuels and chemicals, major barriers remain to achieve efficient microbial platform. 
The efficiency of renewable sugars (cellobiose, xylose, and galactose) utilization is still not as 
efficient compared to conventional glucose fermentation. Also, renewable sugars are derived 
from pretreating lignocellulosic or marine biomass which generates fermentation inhibitors 
during hydrolysis process. Engineered yeasts fermenting renewable sugars should be able to 
tolerate the inhibitors.  
 One of the specific future research that can be achieved is re-investigation of xylose 
genome sequences from QTL analysis (Chapter IV). With different bioinformatics tool, different 
aspects of the data can be analyzed such as gene amplifications that occurred during 
enrichment, etc. Secondly, 2-IPM production can be improved (Chapter VI). With finding 
promising applications of 2-IPM, higher production demand can be anticipated. For instance, 2-
IPM overproducing strains can be further engineered to consume renewable sugars. With these 
goals achieved, efficient production of bio-based production from renewable resources can be 
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